| Effective Date | Policy Name | Reviewed Date |
| 6/16/2021 |
Abecma® (idecabtagene vicleucel)
| 11/19/2025 |
| 6/16/2021 |
Abecma® (idecabtagene vicleucel)
| 2/18/2026 |
| 1/1/2023 |
Abecma® (idecabtagene vicleucel)
| 11/19/2025 |
| 7/1/2024 |
Abecma® (idecabtagene vicleucel)
| 11/19/2025 |
| 1/1/2026 |
Abilify MyCite (aripiprazole tablets with sensor)
| 6/18/2025 |
| 1/1/2023 |
Abraxane (nab- paclitaxel)
| 9/17/2025 |
| 1/1/2023 |
Abraxane (nab-paclitaxel)
| 9/17/2025 |
| 1/1/2023 |
Abraxane (nab-paclitaxel)
| 9/17/2025 |
| 11/1/2025 |
Abraxane (nab-paclitaxel)
| 9/17/2025 |
| 7/27/2022 |
Abuse Deterrent Oxycodone tablets (RoxyBond,Oxaydo, generics)
| 6/18/2025 |
| 7/21/2021 |
Accrufer™ (ferric maltol)
| 5/15/2024 |
| 1/1/2021 |
Acitretin
| 7/16/2025 |
| 1/1/2025 |
Actimmune® (interferon gamma-1b)
| 9/17/2025 |
| 1/1/2022 |
Actinic Keratosis Agents
| 11/19/2025 |
| 1/1/2026 |
Adakveo (crizanlizumab) solution
| 6/18/2025 |
| 1/1/2026 |
Adakveo (crizanlizumab-tmca)
| 6/18/2025 |
| 1/1/2026 |
Adbry® (tralokinumab-ldrm)
| 6/18/2025 |
| 4/27/2022 |
Adbry™ (tralokinumab-ldrm)
| 2/19/2025 |
| 9/1/2011 |
Adcetris® (brentuximab vedotin)
| 4/16/2025 |
| 1/1/2021 |
Adempas® (riociguat)
| 10/15/2025 |
| 1/1/2026 |
Adempas® (riociguat)
| 8/20/2025 |
| 1/1/2024 |
ADHD Long Acting Stimulants
| 7/17/2024 |
| 1/1/2024 |
Adlarity® (donepezil transdermal)
| 11/19/2025 |
| 9/4/2023 |
Adstiladrin (nadofaragene firadenovec-vncg)
| 6/18/2025 |
| 1/19/2024 |
Adstiladrin (nadofaragene firadenovec-vncg)
| 6/18/2025 |
| 11/26/2025 |
Aduhelm (aducanumab-avwa)
| 11/19/2025 |
| 12/15/2021 |
Aduhelm® (aducanumab-avwa)
| 11/19/2025 |
| 4/27/2022 |
Aduhelm® (aducanumab-avwa)
| 11/19/2025 |
| 4/24/2024 |
Adzynma (ADAMTS13, Recombinant-krhn)
| 12/10/2025 |
| 2/1/2026 |
Adzynma (ADAMTS13, recombinant-krhn)
| 12/10/2025 |
| 2/1/2026 |
Adzynma (ADAMTS13, recombinant-krhn)
| 12/10/2025 |
| 2/1/2026 |
Adzynma (ADAMTS13, recombinant-krhn)
| 12/10/2025 |
| 1/1/2024 |
Aemcolo™ (rifamycin)
| 1/21/2026 |
| 1/1/2026 |
Afinitor/Afinitor Disperz (everolimus)
| 2/18/2026 |
| 1/1/2023 |
Aflibercept Products (Eylea®, Eylea® HD, Pavblu™)
| 1/21/2026 |
| 1/1/2025 |
Aflibercept Products (Eylea®, Eylea® HD, Pavblu™)
| 1/21/2026 |
| 3/1/2026 |
Aflibercept Products (Eylea®, Eylea® HD, Pavblu™)
| 1/21/2026 |
| 3/1/2026 |
Aflibercept Products (Eylea®, Eylea® HD, Pavblu™)
| 1/21/2026 |
| 12/31/2014 |
Afrezza® (insulin human) Inhalation Powder
| 10/15/2025 |
| 5/22/2024 |
Agamree® (vamorolone)
| 5/21/2025 |
| 1/1/2026 |
Akeega (niraparib and abiraterone acetate)
| 2/18/2026 |
| 1/1/2023 |
Aklief® (trifarotene)
| 4/16/2025 |
| 1/1/2026 |
Akynzeo (fosnetupitant-palonosetron/netupitant- palonosetron)
| 8/20/2025 |
| 1/1/2013 |
Aldurazyme® (laronidase)
| 6/18/2025 |
| 1/1/2026 |
Alecensa (alectinib)
| 2/18/2026 |
| 1/1/2014 |
Alferon N® (interferon alfa-n3)
| 2/21/2024 |
| 4/23/2025 |
Alhemo® subcutaneous pen injector
| 2/18/2026 |
| 12/20/2017 |
Aliqopa™ (copanlisib)
| 7/16/2025 |
| 1/1/2025 |
Allergy Ophthalmics
| 3/19/2025 |
| 1/1/2026 |
Allergy Ophthalmics
| 8/20/2025 |
| 1/1/2024 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Prolastin-C®)
| 3/19/2025 |
| 1/1/2026 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Prolastin-C®)
| 7/16/2025 |
| 1/1/2026 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Prolastin-C®, Zemaira®)
| 7/16/2025 |
| 1/1/2026 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Prolastin-C®, Zemaira®)
| 7/16/2025 |
| 1/1/2026 |
Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®, Prolastin-C®, Zemaira®)
| 7/16/2025 |
| 1/1/2025 |
Alphagan® P (brimonidine)
| 6/18/2025 |
| 2/26/2025 |
Alternate nilotinib products (Danziten, nilotinib tartrate-Cipla)
| 1/21/2026 |
| 1/1/2026 |
Alunbrig (brigatinib)
| 2/18/2026 |
| 8/28/2024 |
Alvaiz™ (eltrombopag choline) tablet
| 4/16/2025 |
| 1/1/2024 |
Amitiza® (lubiprostone)
| 11/19/2025 |
| 8/18/2021 |
Amivantamab Products (Rybrevant, Rybrevant Faspro)
| 1/21/2026 |
| 7/23/2025 |
Amivantamab Products (Rybrevant, Rybrevant Faspro)
| 1/21/2026 |
| 9/1/2025 |
Amivantamab Products (Rybrevant, Rybrevant Faspro)
| 1/21/2026 |
| 9/1/2025 |
Amivantamab Products (Rybrevant, Rybrevant Faspro)
| 1/21/2026 |
| 6/16/2021 |
Amondys 45 (casimersen)
| 12/10/2025 |
| 1/1/2020 |
Ampyra® (dalfampridine)
| 9/17/2025 |
| 5/28/2025 |
Amvuttra™ (vutrisiran)
| 5/21/2025 |
| 7/1/2025 |
Amvuttra™ (vutrisiran)
| 5/21/2025 |
| 7/23/2025 |
Amzeeq® (minocycline) Topical Foam
| 7/16/2025 |
| 7/23/2025 |
Andembry ® (garadacimab-gxii)
| 7/16/2025 |
| 1/1/2024 |
Angiotensin Blocking & Renin Inhibitor Agents
| 6/19/2024 |
| 1/1/2023 |
Angiotensin Blocking Agents
| 7/16/2025 |
| 6/26/2024 |
Anktiva (nogapendekin alfa inbakicept-pmln)
| 4/16/2025 |
| 1/1/2022 |
Anticholinergic Polypharmacy Agents
| 5/22/2025 |
| 10/1/2025 |
Anticholinergic Polypharmacy Agents - Louisiana Medicaid
| 9/11/2025 |
| 1/1/2019 |
Antipsychotic Utilization Program
| 6/5/2025 |
| 10/1/2025 |
Antipsychotic Utilization Program
| 7/24/2025 |
| 12/17/2025 |
Anzupgo® (delgocitinib)
| 12/10/2025 |
| 1/1/2020 |
Apadaz® (benzhydrocodone and acetaminophen)
| 8/21/2024 |
| 1/1/2022 |
Apokyn® (apomorphine)
| 3/19/2025 |
| 1/1/2026 |
Apokyn® (apomorphine)
| 1/21/2026 |
| 1/1/2024 |
Aptiom® (eslicarbazepine acetate)
| 3/20/2025 |
| 3/26/2025 |
Aqneursa™ (levacetylleucine)
| 2/18/2026 |
| 1/1/2025 |
Aranesp® (darbepoetin alfa)
| 11/19/2025 |
| 4/3/2008 |
Arcalyst® (rilonacept)
| 12/10/2025 |
| 1/1/2020 |
Arikayce® (liposomal amikacin for inhalation)
| 2/18/2026 |
| 12/11/2019 |
Asparlas™ (calaspargase pegol-mknl)
| 10/15/2025 |
| 12/1/2025 |
Asparlas™ (calaspargase pegol-mknl)
| 10/15/2025 |
| 12/1/2025 |
Asparlas™ (calaspargase pegol-mknl)
| 10/15/2025 |
| 12/1/2025 |
Asparlas™ (calaspargase pegol-mknl)
| 10/15/2025 |
| 1/1/2017 |
Aspirin-dipyridamole
| 10/15/2025 |
| 1/1/2024 |
Astagraf XL (tacrolimus extended release)
| 7/17/2024 |
| 1/1/2019 |
Asthma Interleukin Inhibitors (Cinqair®, Nucala™, Fasenra®)
| 8/20/2025 |
| 1/1/2026 |
Asthma Interleukin Inhibitors (Cinqair®, Nucala™, Fasenra®)
| 12/10/2025 |
| 1/1/2025 |
Atezolizumab products (Tecentriq, Tecentriq Hybreza)
| 12/10/2025 |
| 12/1/2025 |
Atezolizumab products (Tecentriq, Tecentriq Hybreza)
| 12/10/2025 |
| 12/1/2025 |
Atezolizumab products (Tecentriq, Tecentriq Hybreza)
| 12/10/2025 |
| 12/1/2025 |
Atezolizumab products (Tecentriq, Tecentriq Hybreza)
| 12/10/2025 |
| 1/1/2024 |
Atgam (antithymocyte immune globulin, equine)
| 6/18/2025 |
| 2/26/2025 |
Attruby™ (acoramidis)
| 5/21/2025 |
| 12/18/2024 |
Aucatzyl (obecabtagene autoleucel)
| 10/15/2025 |
| 2/28/2024 |
Augtyro (repotrectinib)
| 6/18/2025 |
| 1/1/2023 |
Auryxia® (ferric citrate)
| 2/21/2024 |
| 1/1/2022 |
Austedo® & Austedo® XR (deutetrabenazine)
| 6/18/2025 |
| 1/1/2026 |
Auvelity™ (dextromethorphan and bupropion)
| 5/21/2025 |
| 1/1/2025 |
Aveed® (testosterone undecanoate)
| 10/15/2025 |
| 7/23/2025 |
Avmapki (avutometinib)-Fakzynja (defactinib) Co-Pack
| 7/16/2025 |
| 1/1/2026 |
Ayvakit (avapritinib)
| 5/21/2025 |
| 10/17/2018 |
Azedra® (iobenguane I 131)
| 12/10/2025 |
| 1/1/2025 |
Azopt® (brinzolamide ophthalmic suspension)
| 6/18/2025 |
| 11/6/2019 |
Baclofen Products (Fleqsuvy™, baclofen oral solution, baclofen oral suspension, Ozobax™, Lyvispah™)
| 4/17/2024 |
| 1/1/2022 |
Balversa (erdafitinib)
| 2/18/2026 |
| 1/1/2022 |
Banzel® (rufinamide)
| 2/21/2024 |
| 1/1/2025 |
Banzel® (rufinamide)
| 5/21/2025 |
| 1/1/2026 |
Banzel® (rufinamide)
| 5/21/2025 |
| 1/1/2019 |
Bavencio® (avelumab)
| 7/16/2025 |
| 7/24/2014 |
Beleodaq® (belinostat)
| 11/19/2025 |
| 1/1/2026 |
Beleodaq® (belinostat)
| 11/19/2025 |
| 1/1/2026 |
Beleodaq® (belinostat)
| 11/19/2025 |
| 1/1/2026 |
Beleodaq® (belinostat)
| 11/19/2025 |
| 5/1/2021 |
Bempedoic Acid Products
| 2/19/2025 |
| 1/1/2023 |
Bendamustine products (Treanda, Bendeka, Belrapzo, Vivimusta)
| 2/18/2026 |
| 1/1/2026 |
Bendamustine products (Treanda, Bendeka, Belrapzo, Vivimusta)
| 8/20/2025 |
| 1/1/2022 |
Benlysta® (belimumab)
| 7/16/2025 |
| 1/1/2026 |
Benlysta® (belimumab)
| 7/16/2025 |
| 7/1/2024 |
Benzodiazepine Limited Days Supply
| 6/5/2025 |
| 1/1/2019 |
Benzodiazepine Limited Days' Supply
| 4/24/2025 |
| 1/1/2023 |
Beovu® (brolucizumab)
| 1/21/2026 |
| 7/1/2024 |
Beovu® (brolucizumab)
| 1/21/2026 |
| 1/1/2025 |
Beovu® (brolucizumab)
| 1/21/2026 |
| 10/1/2025 |
Beovu® (brolucizumab)
| 9/17/2025 |
| 10/1/2025 |
Beovu® (brolucizumab)
| 1/21/2026 |
| 7/24/2024 |
Beqvez™ intravenous suspension
| 11/19/2025 |
| 1/1/2025 |
Berinert (C1 esterase inhibitor, human)
| 8/20/2025 |
| 10/1/2025 |
Berinert (C1 esterase inhibitor, human)
| 8/20/2025 |
| 1/1/2019 |
Besponsa™ (inotuzumab ozogamicin)
| 11/19/2025 |
| 1/1/2026 |
Besponsa™ (inotuzumab ozogamicin)
| 11/19/2025 |
| 1/1/2026 |
Besponsa™ (inotuzumab ozogamicin)
| 11/19/2025 |
| 1/1/2026 |
Besponsa™ (inotuzumab ozogamicin)
| 11/19/2025 |
| 2/16/2022 |
Besremi (ropeginterferon alfa-2b-njft)
| 11/19/2025 |
| 1/1/2026 |
Bevacizumab products
| 9/17/2025 |
| 1/1/2026 |
Bevacizumab products
| 9/17/2025 |
| 1/1/2026 |
Bevacizumab products
| 9/17/2025 |
| 1/1/2026 |
Bevacizumab products
| 9/17/2025 |
| 1/1/2021 |
Bexarotene products (Targretin capsules and gel, bexarotene capsules and gel)
| 7/16/2025 |
| 1/1/2022 |
BiDil® (isosorbide dinitrate/hydralazine)
| 5/21/2025 |
| 1/1/2019 |
Biguanide Agents
| 10/15/2025 |
| 1/1/2025 |
Bimzelx (bimekizumab-bkzx)
| 6/18/2025 |
| 1/1/2026 |
Bimzelx (bimekizumab-bkzx)
| 7/16/2025 |
| 1/1/2017 |
Bisphosphonates
| 2/18/2026 |
| 11/26/2025 |
Bizengri (zenocutuzumab-zbco)
| 11/19/2025 |
| 1/1/2026 |
Bizengri (zenocutuzumab-zbco)
| 11/19/2025 |
| 1/1/2026 |
Bizengri (zenocutuzumab-zbco)
| 11/19/2025 |
| 1/1/2026 |
Bizengri (zenocutuzumab-zbco)
| 11/19/2025 |
| 10/14/2020 |
Blenrep (belantamab mafodotin-blmf)
| 12/10/2025 |
| 1/1/2020 |
Blincyto® (blinatumomab)
| 8/20/2025 |
| 10/1/2025 |
Blincyto® (blinatumomab)
| 8/20/2025 |
| 10/1/2025 |
Blincyto® (blinatumomab)
| 8/20/2025 |
| 10/1/2025 |
Blincyto® (blinatumomab)
| 8/20/2025 |
| 1/1/2022 |
Bortezomib products (Velcade and Bortezomib for injection)
| 2/18/2026 |
| 9/1/2025 |
Bortezomib products (Velcade and Bortezomib for injection)
| 2/18/2026 |
| 9/1/2025 |
Bortezomib products (Velcade and Bortezomib for injection)
| 2/18/2026 |
| 9/1/2025 |
Bortezomib products (Velcade and Bortezomib for injection)
| 2/18/2026 |
| 1/1/2022 |
Bosentan Products
| 7/16/2025 |
| 1/1/2022 |
Bosulif® (bosutinib)
| 5/1/2025 |
| 1/1/2024 |
Botox® (onabotulinumtoxinA)
| 6/18/2025 |
| 7/1/2024 |
Botox® (onabotulinumtoxinA)
| 6/18/2025 |
| 7/1/2024 |
Botox® (onabotulinumtoxinA)
| 6/18/2025 |
| 1/1/2026 |
Botox® (onabotulinumtoxinA)
| 11/19/2025 |
| 1/1/2022 |
Bowel Prep Agents
| 5/15/2024 |
| 1/1/2024 |
Bowel Prep Agents
| 5/15/2024 |
| 1/1/2025 |
Bowel Prep Agents
| 5/21/2025 |
| 1/1/2016 |
BPH Agents
| 4/17/2024 |
| 1/1/2026 |
Braftovi (encorafenib)
| 6/18/2025 |
| 12/17/2025 |
Brekiya® (dihydroergotamine mesylate)
| 12/10/2025 |
| 3/17/2021 |
Breyanzi® (lisocabtagene maraleucel)
| 2/18/2026 |
| 1/1/2023 |
Breyanzi® (lisocabtagene maraleucel)
| 1/21/2026 |
| 7/1/2024 |
Breyanzi® (lisocabtagene maraleucel)
| 1/21/2026 |
| 4/21/2021 |
Breyanzi® (lisocabtagene maraleucel)
| 1/21/2026 |
| 1/1/2024 |
Breztri Aerosphere™ (budesonide/glycopyrrolate/formoterol fumarate)
| 6/19/2024 |
| 7/19/2017 |
Brineura™ (cerliponase alfa)
| 4/16/2025 |
| 11/26/2025 |
Brinsupri™ (brensocatib)
| 11/19/2025 |
| 6/7/2023 |
Briumvi™ (ublituximab)
| 2/21/2024 |
| 6/7/2023 |
Briumvi™ (ublituximab)
| 10/15/2025 |
| 1/1/2026 |
Briumvi™ (ublituximab)
| 2/18/2026 |
| 1/1/2026 |
Briviact® (brivaracetam)
| 5/21/2025 |
| 5/19/2021 |
Bronchitol® (mannitol)
| 12/10/2025 |
| 1/1/2023 |
Brukinsa™ (zanubrutinib)
| 4/16/2025 |
| 1/1/2025 |
Buprenorphine and Naloxone Containing Products
| 6/18/2025 |
| 1/1/2020 |
Buprenorphine Containing Products
| 5/15/2024 |
| 1/1/2026 |
Buprenorphine weekly transdermal patch
| 6/18/2025 |
| 1/1/2026 |
Bupropion Containing Products (Aplenzin®, Forfivo XL®)
| 6/18/2025 |
| 11/17/2021 |
Bylvay (odevixibat)
| 3/19/2025 |
| 1/1/2026 |
Bylvay (odevixibat)
| 6/18/2025 |
| 11/26/2025 |
Bynfezia Pen® (octreotide acetate) injection
| 11/19/2025 |
| 8/19/2020 |
Bynfezia Pen™ (octreotide acetate) injection
| 2/21/2024 |
| 6/22/2022 |
Byooviz® (ranibizumab-nuna)
| 2/18/2026 |
| 1/1/2024 |
Byooviz® (ranibizumab-nuna)
| 2/18/2026 |
| 2/25/2026 |
Byooviz® (ranibizumab-nuna)
| 2/18/2026 |
| 5/15/2019 |
Cablivi® (caplacizumab-yhdp)
| 12/10/2025 |
| 1/1/2021 |
Cabometyx (cabozantinib)
| 2/18/2026 |
| 9/1/2022 |
Calcitonin gene-related peptide (CGRP) inhibitors
| 3/27/2024 |
| 1/1/2025 |
Calcitonin gene-related peptide (CGRP) inhibitors
| 12/10/2025 |
| 1/1/2024 |
Calcium Channel Blocking Agents
| 2/18/2026 |
| 1/1/2021 |
Calquence® (acalabrutinib)
| 4/16/2025 |
| 1/1/2026 |
Camcevi (leuprolide mesylate)
| 11/19/2025 |
| 10/26/2022 |
Camzyos™ (mavacamten)
| 10/15/2025 |
| 1/1/2024 |
Caplyta (lumateperone)
| 7/17/2024 |
| 1/1/2025 |
Caplyta® (lumateperone)
| 12/10/2025 |
| 1/1/2026 |
Caprelsa (vandetanib)
| 5/21/2025 |
| 11/24/2010 |
Carbaglu® (carglumic acid)
| 11/19/2025 |
| 1/1/2025 |
Carbidopa/Levodopa Extended-Release Products
| 9/17/2025 |
| 2/25/2026 |
Cardamyst™ (etripamil)
| 2/18/2026 |
| 1/1/2024 |
CaroSpir® (spironolactone) oral suspension
| 4/16/2025 |
| 4/27/2022 |
Carvykti™ (ciltacabtagene autoleucel)
| 2/18/2026 |
| 1/1/2023 |
Carvykti™ (ciltacabtagene autoleucel)
| 11/19/2025 |
| 7/1/2024 |
Carvykti™ (ciltacabtagene autoleucel)
| 11/19/2025 |
| 11/26/2025 |
Carvykti™ (ciltacabtagene autoleucel)
| 11/19/2025 |
| 4/27/2022 |
Carvykti™ (ciltacabtagene autoleucel)
| 11/19/2025 |
| 1/1/2019 |
Cayston® (aztreonam inhalation solution)
| 12/10/2025 |
| 9/18/2014 |
Cerdelga® (eliglustat)
| 6/19/2024 |
| 1/1/2025 |
Cerdelga® (eliglustat)
| 4/16/2025 |
| 1/1/2025 |
Cerezyme (imiglucerase)
| 4/16/2025 |
| 1/1/2025 |
CFTR Modulators
| 2/19/2025 |
| 1/1/2026 |
CFTR Modulators
| 5/21/2025 |
| 1/1/2015 |
Chenodal™ (chenodiol)
| 8/20/2025 |
| 1/1/2024 |
Cialis (tadalafil)
| 5/21/2025 |
| 1/1/2026 |
Cialis (tadalafil)
| 5/21/2025 |
| 5/25/2022 |
Cibinqo® (abrocitinib)
| 12/10/2025 |
| 10/1/2023 |
Cimerli® (ranibizumab-eqrn)
| 2/19/2025 |
| 7/1/2024 |
Cimerli® (ranibizumab-eqrn)
| 2/19/2025 |
| 7/1/2025 |
Cimzia (certolizumab pegol)
| 6/18/2025 |
| 1/1/2026 |
Cimzia (certolizumab pegol)
| 7/16/2025 |
| 1/1/2022 |
Cimzia® (certolizumab pegol)
| 9/18/2024 |
| 1/1/2025 |
Cinryze (C1 esterase inhibitor, human)
| 8/20/2025 |
| 10/1/2025 |
Cinryze (C1 esterase inhibitor, human)
| 8/20/2025 |
| 1/1/2020 |
Cinvanti (aprepitant) emulsion
| 4/16/2025 |
| 1/1/2026 |
Clemastine fumarate syrup
| 1/21/2026 |
| 1/1/2020 |
Clindagel® (clindamycin phosphate gel)
| 10/15/2025 |
| 10/19/2016 |
Clinical Trials Policy
| 7/16/2025 |
| 1/1/2026 |
Clozapine orally disintegrating tablet and Versacloz® (clozapine oral solution)
| 12/11/2025 |
| 1/20/2017 |
Coagadex® (Coagulation Factor X [Human])
| 12/10/2025 |
| 2/1/2026 |
Coagadex® (Coagulation Factor X [Human])
| 12/10/2025 |
| 11/27/2024 |
Cobenfy™ (xanomeline-trospium)
| 9/17/2025 |
| 1/1/2025 |
Colchicine Products
| 4/16/2025 |
| 9/27/2023 |
Columvi™ (glofitamab-gxbm)
| 2/18/2026 |
| 1/1/2026 |
Columvi™ (glofitamab-gxbm)
| 2/18/2026 |
| 1/1/2026 |
Cometriq (cabozantinib)
| 1/21/2026 |
| 1/1/2021 |
Compounded Medications
| 7/16/2025 |
| 3/23/2023 |
Continuity of Care
| 5/15/2025 |
| 5/16/2013 |
Continuity of Care
| 5/15/2025 |
| 4/1/2024 |
Continuity of Care
| 5/15/2025 |
| 5/12/2025 |
Continuity of Care
| 5/15/2025 |
| 7/1/2025 |
Continuity of Care
| 5/15/2025 |
| 7/1/2024 |
Continuity of Care
| 1/8/2026 |
| 1/1/2016 |
Continuous Glucose Monitoring Systems
| 3/20/2024 |
| 6/3/2020 |
Contraceptive Medications
| 2/21/2024 |
| 12/12/2018 |
Copiktra™ (duvelisib)
| 12/10/2025 |
| 1/1/2021 |
Coreg CR® (carvedilol ER)
| 5/15/2024 |
| 1/20/2017 |
Corifact® (Factor XIII Concentrate [Human])
| 12/10/2025 |
| 1/1/2022 |
Corlanor® (ivabradine)
| 4/16/2025 |
| 1/1/2026 |
Corlanor® (ivabradine)
| 10/15/2025 |
| 1/1/2024 |
Corticotropin Products
| 4/17/2024 |
| 1/1/2025 |
Corticotropin Products
| 5/21/2025 |
| 4/21/2021 |
Cosela™ (trilaciclib)
| 9/17/2025 |
| 11/1/2025 |
Cosela™ (trilaciclib)
| 9/17/2025 |
| 11/1/2025 |
Cosela™ (trilaciclib)
| 9/17/2025 |
| 11/1/2025 |
Cosela™ (trilaciclib)
| 9/17/2025 |
| 1/1/2025 |
Cosentyx (secukinumab) intravenous solution
| 7/16/2025 |
| 1/1/2022 |
Cosentyx (secukinumab) subcutaneous solution
| 2/19/2025 |
| 1/1/2026 |
Cosentyx (secukinumab) subcutaneous solution
| 8/20/2025 |
| 1/1/2026 |
Cosentyx (secukinumab) subcutaneous solution
| 8/20/2025 |
| 1/1/2016 |
Cosopt® (dorzolamide and timolol ophthalmic solution)
| 4/16/2025 |
| 1/1/2026 |
Cotellic (cobimetinib)
| 6/18/2025 |
| 1/1/2006 |
Cough and Cold Medications
| 8/20/2025 |
| 5/28/2025 |
Crenessity (crinecerfont)
| 5/21/2025 |
| 5/28/2015 |
Cresemba® (isavuconazonium sulfate)
| 2/18/2026 |
| 3/7/2013 |
Crofelemer Products
| 1/21/2026 |
| 1/1/2020 |
Crotamiton Topical Products
| 11/19/2025 |
| 1/1/2020 |
Crysvita® (burosumab)
| 2/18/2026 |
| 4/23/2025 |
Ctexli (chenodiol)
| 2/18/2026 |
| 5/24/2023 |
Cuvrior™ (trientine tetrahydrochloride)
| 12/10/2025 |
| 1/1/2017 |
Cycloset® (bromocriptine)
| 9/17/2025 |
| 1/1/2013 |
Cyklokapron® (tranexamic acid)
| 6/18/2025 |
| 1/1/2025 |
Cyramza (ramucirumab)
| 1/21/2026 |
| 3/1/2026 |
Cyramza (ramucirumab)
| 1/21/2026 |
| 3/1/2026 |
Cyramza (ramucirumab)
| 1/21/2026 |
| 3/1/2026 |
Cyramza (ramucirumab)
| 1/21/2026 |
| 5/9/2013 |
Cysteamine Ophthalmic Products (Cystaran®, Cystadrops®)
| 8/20/2025 |
| 1/1/2013 |
Cytogam® (cytomegalovirus immune globulin, human)
| 6/18/2025 |
| 5/16/2025 |
Cytotec® (misoprostol)
| 4/16/2025 |
| 2/17/2021 |
Danyelza® (naxitamab-gqgk)
| 11/19/2025 |
| 1/1/2026 |
Danyelza® (naxitamab-gqgk)
| 11/19/2025 |
| 1/1/2026 |
Danyelza® (naxitamab-gqgk)
| 11/19/2025 |
| 1/1/2026 |
Danyelza® (naxitamab-gqgk)
| 11/19/2025 |
| 2/23/2022 |
Dartisla ODT (glycopyrrolate)
| 10/15/2025 |
| 1/1/2022 |
Darzalex Faspro™ (daratumumab and hyaluronidase-fihj)
| 4/16/2025 |
| 1/1/2022 |
Darzalex® (daratumumab)
| 1/21/2026 |
| 3/1/2026 |
Darzalex® (daratumumab)
| 1/21/2026 |
| 3/1/2026 |
Darzalex® (daratumumab)
| 1/21/2026 |
| 3/1/2026 |
Darzalex® (daratumumab)
| 1/21/2026 |
| 1/1/2026 |
Dasatinib products
| 10/15/2025 |
| 3/26/2025 |
Datroway (datopotamab deruxtecan-dlnk)
| 9/17/2025 |
| 11/1/2025 |
Datroway (datopotamab deruxtecan-dlnk)
| 9/17/2025 |
| 11/1/2025 |
Datroway (datopotamab deruxtecan-dlnk)
| 9/17/2025 |
| 11/1/2025 |
Datroway (datopotamab deruxtecan-dlnk)
| 9/17/2025 |
| 1/1/2026 |
Daurismo™ (glasdegib)
| 5/21/2025 |
| 10/22/2025 |
Dawnzera™ (donidalorsen)
| 10/15/2025 |
| 1/1/2024 |
Daxxify® (daxibotulinumtoxinA-lanm)
| 4/16/2025 |
| 7/1/2024 |
Daxxify® (daxibotulinumtoxinA-lanm)
| 4/16/2025 |
| 1/1/2026 |
Daxxify® (daxibotulinumtoxinA-lanm)
| 8/20/2025 |
| 1/1/2026 |
Daxxify® (daxibotulinumtoxinA-lanm)
| 11/19/2025 |
| 5/24/2023 |
Daybue™ (trofinetide)
| 2/18/2026 |
| 1/1/2022 |
Dayvigo™ (lemborexant)
| 12/10/2025 |
| 1/1/2026 |
Deferasirox Products
| 6/18/2025 |
| 1/1/2022 |
Defitelio® (defibrotide sodium)
| 8/20/2025 |
| 1/1/2026 |
Defitelio® (defibrotide sodium)
| 8/20/2025 |
| 1/1/2022 |
Desmopressin Nasal Spray
| 4/17/2024 |
| 1/1/2025 |
Desmopressin Nasal Spray
| 12/10/2025 |
| 1/1/2020 |
Desvenlafaxine Containing Products
| 3/20/2024 |
| 1/1/2020 |
Desvenlafaxine Extended-Release
| 3/19/2025 |
| 1/1/2022 |
Dexchlorpheniramine oral solution
| 1/15/2025 |
| 1/1/2023 |
Dexilant® (dexlansoprazole)
| 2/21/2024 |
| 1/1/2017 |
Diabetic Test Strips and Meters
| 7/16/2025 |
| 1/1/2023 |
Diacomit® (stiripentol)
| 10/15/2025 |
| 10/15/2015 |
Dichlorphenamide Products
| 9/17/2025 |
| 1/1/2023 |
Differin® (adapalene) and Epiduo® (adapalene and benzoyl peroxide)
| 4/17/2024 |
| 1/1/2022 |
Dihydroergotamine Products
| 9/17/2025 |
| 9/2/2020 |
Dojolvi™ (triheptanoin) Oral Liquid
| 1/21/2026 |
| 1/1/2021 |
Dopamine Agonists
| 6/19/2024 |
| 1/1/2023 |
Dopamine Agonists
| 11/19/2025 |
| 1/1/2025 |
Doptelet® (Avatrombopag) Products
| 12/10/2025 |
| 1/1/2021 |
Doxycycline Antibiotics
| 7/16/2025 |
| 1/1/2021 |
DPP-IV inhibitors
| 2/21/2024 |
| 1/1/2026 |
DPP-IV inhibitors
| 7/16/2025 |
| 1/1/2024 |
DPP-IV, SGLT2 Combination Products
| 6/19/2024 |
| 1/1/2026 |
DPP-IV, SGLT2 Combination Products
| 7/16/2025 |
| 1/1/2014 |
Dronabinol (GENERIC)
| 8/21/2024 |
| 1/1/2014 |
Dronabinol containing products (BRAND)
| 8/21/2024 |
| 1/24/2019 |
Drug Management Program-Opioid Program
| 7/16/2025 |
| 8/28/2010 |
Drug Utilization Management and Clinical Edits Tools
| 11/19/2025 |
| 10/1/2025 |
Drug Utilization Management and Clinical Edits Tools
| 9/18/2025 |
| 1/1/2024 |
Duavee® (conjugated estrogens/bazedoxifene tablet)
| 5/21/2025 |
| 1/1/2026 |
Duexis (ibuprofen-famotidine)
| 5/21/2025 |
| 1/1/2020 |
Duexis® (ibuprofen-famotidine)
| 4/16/2025 |
| 10/16/2019 |
Duloxetine Containing Products
| 9/17/2025 |
| 1/1/2021 |
Duobrii® (halobetasol propionate and tazarotene)
| 2/18/2026 |
| 1/1/2024 |
Duopa® (carbidopa and levodopa)
| 1/21/2026 |
| 7/1/2024 |
Duopa® (carbidopa and levodopa)
| 1/21/2026 |
| 1/1/2026 |
Dupixent® (dupilumab) injection
| 10/15/2025 |
| 8/19/2020 |
Durysta® (bimatoprost implant)
| 11/19/2025 |
| 1/1/2026 |
Durysta® (bimatoprost implant)
| 11/19/2025 |
| 1/1/2026 |
Durysta® (bimatoprost implant)
| 11/19/2025 |
| 9/25/2024 |
Duvyzat (givinostat)
| 9/17/2025 |
| 1/1/2024 |
Dysport® (abobotulinumtoxinA)
| 6/18/2025 |
| 7/1/2024 |
Dysport® (abobotulinumtoxinA)
| 6/18/2025 |
| 1/1/2026 |
Dysport® (abobotulinumtoxinA)
| 11/19/2025 |
| 3/13/2024 |
Early Refill Edits on Topical Ophthalmic Products
| 1/26/2026 |
| 1/1/2026 |
Ebglyss™ (lebrikizumab-lbkx) subcutaneous
| 6/18/2025 |
| 12/16/2010 |
Egrifta® (tesamorelin acetate)
| 9/17/2025 |
| 8/27/2025 |
Ekterly® (sebetralstat)
| 8/20/2025 |
| 1/1/2023 |
Elahere (mirvetuximab soravtansine-gynx)
| 4/16/2025 |
| 1/1/2026 |
Elahere (mirvetuximab soravtansine-gynx)
| 8/20/2025 |
| 9/29/2008 |
Elaprase® (idursulfase)
| 8/20/2025 |
| 10/1/2025 |
Elaprase® (idursulfase)
| 8/20/2025 |
| 5/22/2012 |
Elelyso® (taliglucerase alfa)
| 4/16/2025 |
| 9/27/2023 |
Elevidys (delandistrogene moxeparvovec-rokl)
| 12/10/2025 |
| 1/1/2024 |
Elidel® (pimecrolimus)
| 2/18/2026 |
| 1/1/2026 |
Eligard (leuprolide acetate)
| 8/20/2025 |
| 10/22/2025 |
Eliquis® (apixaban) Sprinkle & Tablet for Oral Suspension
| 10/15/2025 |
| 1/1/2012 |
Elitek® (rasburicase)
| 8/20/2025 |
| 10/1/2025 |
Elitek® (rasburicase)
| 8/20/2025 |
| 10/1/2025 |
Elitek® (rasburicase)
| 8/20/2025 |
| 11/15/2023 |
Elrexfio (elranatamab-bcmm)
| 9/17/2025 |
| 11/1/2025 |
Elrexfio (elranatamab-bcmm)
| 9/17/2025 |
| 11/1/2025 |
Elrexfio (elranatamab-bcmm)
| 9/17/2025 |
| 1/1/2026 |
Elrexfio (elranatamab-bcmm)
| 8/20/2025 |
| 1/1/2023 |
Elzonris™ (tagraxofusp-erzs)
| 1/21/2026 |
| 3/1/2026 |
Elzonris™ (tagraxofusp-erzs)
| 1/21/2026 |
| 3/1/2026 |
Elzonris™ (tagraxofusp-erzs)
| 1/21/2026 |
| 3/1/2026 |
Elzonris™ (tagraxofusp-erzs)
| 1/21/2026 |
| 1/1/2020 |
Emflaza® (deflazacort)
| 10/15/2025 |
| 1/1/2024 |
Empaveli (pegcetacoplan)
| 9/17/2025 |
| 1/1/2022 |
Empliciti (elotuzumab)
| 2/18/2026 |
| 9/1/2025 |
Empliciti (elotuzumab)
| 2/18/2026 |
| 10/1/2025 |
Empliciti (elotuzumab)
| 8/20/2025 |
| 10/1/2025 |
Empliciti (elotuzumab)
| 8/20/2025 |
| 10/1/2025 |
Empliciti (elotuzumab)
| 2/18/2026 |
| 10/1/2025 |
Empliciti (elotuzumab)
| 2/18/2026 |
| 7/23/2025 |
Emrelis (telisotuzumab vedotin-tllv)
| 7/16/2025 |
| 9/1/2025 |
Emrelis (telisotuzumab vedotin-tllv)
| 7/16/2025 |
| 9/1/2025 |
Emrelis (telisotuzumab vedotin-tllv)
| 7/16/2025 |
| 9/1/2025 |
Emrelis (telisotuzumab vedotin-tllv)
| 7/16/2025 |
| 7/23/2025 |
Emrosi™ (minocycline)
| 7/16/2025 |
| 1/1/2022 |
EMSAM® (selegiline transdermal system)
| 2/18/2026 |
| 1/1/2025 |
Enbrel (etanercept)
| 6/18/2025 |
| 1/1/2026 |
Enbrel (etanercept)
| 7/16/2025 |
| 1/28/2026 |
Enbumyst (bumetanide)
| 1/21/2026 |
| 5/28/2025 |
Encelto™ (revakinagene taroretcel-lwey) Implant
| 10/15/2025 |
| 1/1/2023 |
Enhertu (fam-trastuzumab deruxtecan-nxki)
| 4/16/2025 |
| 7/27/2022 |
Enjaymo™ (sutimlimab-jome)
| 7/16/2025 |
| 7/23/2025 |
Enjaymo™ sutimlimab-jome
| 7/16/2025 |
| 2/25/2026 |
Ensacove (ensartinib)
| 1/29/2026 |
| 1/20/2021 |
Enspryng® (satralizumab-mwge)
| 7/16/2025 |
| 1/1/2026 |
Enspryng® (satralizumab-mwge)
| 8/20/2025 |
| 1/1/2026 |
Entresto® (sacubitril-valsartan)
| 6/18/2025 |
| 1/1/2025 |
Entyvio (vedolizumab)
| 6/18/2025 |
| 1/1/2019 |
Envarsus XR® (tacrolimus extended-release)
| 2/18/2026 |
| 5/22/2024 |
Eohilia™ (budesonide oral suspension)
| 2/19/2025 |
| 1/1/2026 |
Eohilia™ (budesonide oral suspension)
| 6/18/2025 |
| 1/1/2025 |
Epclusa (sofosbuvir velpatasvir)
| 6/18/2025 |
| 1/1/2024 |
Epidiolex® (cannabidiol)
| 4/16/2025 |
| 1/1/2019 |
EpiPen® and EpiPen Jr® (epinephrine)
| 1/17/2024 |
| 8/23/2023 |
Epkinly™ (epcoritamab-bysp)
| 2/18/2026 |
| 11/1/2025 |
Epkinly™ (epcoritamab-bysp)
| 9/17/2025 |
| 11/1/2025 |
Epkinly™ (epcoritamab-bysp)
| 9/17/2025 |
| 1/1/2026 |
Epkinly™ (epcoritamab-bysp)
| 8/20/2025 |
| 1/1/2024 |
Eplerenone Products
| 4/16/2025 |
| 1/1/2025 |
Epoetin Alfa (Epogen, Procrit, Retacrit)
| 11/19/2025 |
| 1/1/2024 |
Epoprostenol Products
| 3/19/2025 |
| 1/1/2026 |
Epoprostenol Products
| 9/17/2025 |
| 1/1/2026 |
Eprontia® (topiramate) oral solution
| 5/21/2025 |
| 1/1/2021 |
Equetro® (carbamazepine)
| 2/18/2026 |
| 1/1/2024 |
Erbitux (cetuximab)
| 12/10/2025 |
| 2/1/2026 |
Erbitux (cetuximab)
| 12/10/2025 |
| 2/1/2026 |
Erbitux (cetuximab)
| 12/10/2025 |
| 2/1/2026 |
Erbitux (cetuximab)
| 12/10/2025 |
| 2/9/2012 |
Erivedge® (vismodegib)
| 9/17/2025 |
| 1/1/2026 |
Erleada (apalutamide)
| 5/21/2025 |
| 1/1/2019 |
Erwinase® (asparaginase Erwinia chrysanthemi)
| 9/17/2025 |
| 11/1/2025 |
Erwinase® (asparaginase Erwinia chrysanthemi)
| 9/17/2025 |
| 11/1/2025 |
Erwinase® (asparaginase Erwinia chrysanthemi)
| 9/17/2025 |
| 11/1/2025 |
Erwinase® (asparaginase Erwinia chrysanthemi)
| 9/17/2025 |
| 1/1/2023 |
Esbriet® (pirfenidone)
| 1/21/2026 |
| 1/1/2026 |
Eucrisa® (crisaborole)
| 5/21/2025 |
| 1/1/2023 |
Eulexin (Flutamide)
| 2/18/2026 |
| 1/1/2023 |
Evenity® (romosozumab-aqqg)
| 2/18/2026 |
| 1/1/2021 |
Evista (raloxifene)
| 3/20/2024 |
| 3/17/2021 |
Evkeeza™ (evinacumab-dgnb)
| 2/19/2025 |
| 1/1/2026 |
Evkeeza™ (evinacumab-dgnb)
| 7/16/2025 |
| 1/1/2026 |
Evkeeza™ (evinacumab-dgnb)
| 7/16/2025 |
| 11/11/2020 |
Evrysdi® (risdiplam)
| 9/17/2025 |
| 11/17/2021 |
Exkivity (mobocertinib)
| 6/18/2025 |
| 1/1/2022 |
Exondys 51 (eteplirsen)
| 12/10/2025 |
| 8/18/2021 |
Exservan™ (riluzole)
| 6/18/2025 |
| 12/17/2025 |
Exxua (gepirone)
| 12/10/2025 |
| 1/1/2023 |
Eysuvis™ (loteprednol etabonate)
| 1/17/2024 |
| 1/1/2021 |
Ezetimibe-Containing Products
| 5/15/2024 |
| 5/22/2024 |
Fabhalta® (iptacopan) capsule
| 7/16/2025 |
| 1/1/2012 |
Fabrazyme® (agalsidase beta) and Elfabrio® (pegunigalsidase alfa)
| 12/10/2025 |
| 2/1/2026 |
Fabrazyme® (agalsidase beta) and Elfabrio® (pegunigalsidase alfa)
| 12/10/2025 |
| 2/1/2026 |
Fabrazyme® (agalsidase beta) and Elfabrio® (pegunigalsidase alfa)
| 12/10/2025 |
| 1/20/2017 |
Factor IX Replacement Products (Hemophilia B)
| 12/10/2025 |
| 12/17/2025 |
Factor IX Replacement Products (Hemophilia B)
| 12/10/2025 |
| 1/20/2017 |
Factor VIII Replacement Products (Hemophilia A)
| 12/10/2025 |
| 12/17/2025 |
Factor VIII Replacement Products (Hemophilia A)
| 12/10/2025 |
| 1/1/2024 |
Fanapt® (iloperidone)
| 1/21/2026 |
| 1/1/2025 |
Faslodex (fulvestrant)
| 9/17/2025 |
| 11/1/2025 |
Faslodex (fulvestrant)
| 9/17/2025 |
| 11/1/2025 |
Faslodex (fulvestrant)
| 9/17/2025 |
| 1/1/2020 |
FazaClo® (clozapine orally disintegrating tablet) and Versacloz® (clozapine oral solution)
| 7/17/2024 |
| 7/20/2017 |
FEIBA NF (Anti-Inhibitor Coagulant Complex)
| 6/18/2025 |
| 1/1/2026 |
Felbatol® (felbamate)
| 5/21/2025 |
| 7/15/2020 |
Fensolvi® (leuprolide acetate) subcutaneous syringe
| 11/19/2025 |
| 1/1/2026 |
Fensolvi® (leuprolide acetate) subcutaneous syringe
| 8/20/2025 |
| 1/1/2024 |
Ferriprox® (deferiprone)
| 8/20/2025 |
| 1/1/2022 |
Fetzima® (levomilnacipran)
| 8/20/2025 |
| 1/1/2017 |
Fibrate Products
| 11/19/2025 |
| 1/1/2020 |
Fibrate Products
| 1/17/2024 |
| 8/23/2023 |
FILSPARI® (sparsentan)
| 10/15/2025 |
| 5/22/2024 |
Filsuvez® (birch triterpenes)
| 2/18/2026 |
| 1/1/2024 |
Fintepla® (fenfluramine)
| 4/17/2024 |
| 1/1/2025 |
Fintepla® (fenfluramine)
| 5/21/2025 |
| 1/1/2025 |
Firazyr (icatibant)
| 1/15/2026 |
| 1/1/2026 |
Firazyr (icatibant)
| 8/20/2025 |
| 1/1/2020 |
Firdapse® (amifampridine)
| 10/15/2025 |
| 1/1/2026 |
Firmagon (degarelix)
| 5/21/2025 |
| 1/1/2021 |
Flector®, Licart™ (diclofenac epolamine patch 1.3%)
| 6/18/2025 |
| 9/5/2018 |
Florida Statute 456.44(5)(a) Opioid Days' Supply Limitation
| 11/21/2024 |
| 10/29/2009 |
Folotyn® (pralatrexate)
| 11/19/2025 |
| 1/1/2026 |
Folotyn® (pralatrexate)
| 11/19/2025 |
| 1/1/2026 |
Folotyn® (pralatrexate)
| 11/19/2025 |
| 1/1/2026 |
Folotyn® (pralatrexate)
| 11/19/2025 |
| 1/1/2021 |
Foot Bath Medications
| 5/21/2025 |
| 10/15/2025 |
Foot Bath Medications
| 10/16/2025 |
| 1/1/2019 |
Formulary Tier Exception
| 2/19/2026 |
| 1/1/2019 |
Forteo® (teriparatide injection)
| 3/19/2025 |
| 1/1/2026 |
Forteo® (teriparatide injection)
| 2/18/2026 |
| 2/25/2026 |
Forzinity™ (Elamipretide)
| 2/18/2026 |
| 1/1/2026 |
Fosaprepitant products (Emend, Focinvez)
| 8/20/2025 |
| 5/19/2021 |
Fotivda (tivozanib)
| 12/10/2025 |
| 1/24/2024 |
Fruzaqla (fruquintinib)
| 8/20/2025 |
| 12/28/2022 |
Furoscix® (furosemide)
| 12/10/2025 |
| 11/26/2025 |
Fyarro (sirolimus protein-bound particles for injectable suspension)
| 11/19/2025 |
| 1/1/2026 |
Fyarro (sirolimus protein-bound particles for injectable suspension)
| 11/19/2025 |
| 1/1/2026 |
Fyarro (sirolimus protein-bound particles for injectable suspension)
| 11/19/2025 |
| 2/23/2022 |
Fyarro (sirolimus protein-bound particles for injectable suspension)
| 11/19/2025 |
| 1/1/2023 |
Fycompa® (perampanel)
| 11/19/2025 |
| 9/26/2018 |
Galafold®(migalastat)
| 12/10/2025 |
| 11/1/2025 |
Gamifant® (emapalumab-lzsg)
| 9/17/2025 |
| 11/1/2025 |
Gamifant® (emapalumab-lzsg)
| 9/17/2025 |
| 11/1/2025 |
Gamifant® (emapalumab-lzsg)
| 9/17/2025 |
| 4/23/2019 |
Gamifant® (emapalumab-lzsg)
| 9/17/2025 |
| 1/1/2019 |
Gattex® (teduglutide)
| 8/20/2025 |
| 11/11/2020 |
Gavreto (pralsetinib)
| 6/18/2025 |
| 1/1/2020 |
Gazyva® (obinutuzumab)
| 12/10/2025 |
| 2/1/2026 |
Gazyva® (obinutuzumab)
| 12/10/2025 |
| 2/1/2026 |
Gazyva® (obinutuzumab)
| 12/10/2025 |
| 2/1/2026 |
Gazyva® (obinutuzumab)
| 12/10/2025 |
| 1/1/2020 |
Gilotrif (afatinib)
| 10/15/2025 |
| 1/20/2021 |
Gimoti™ (metoclopramide)
| 8/20/2025 |
| 3/18/2020 |
Givlaari® (givosiran)
| 8/20/2025 |
| 10/1/2025 |
Givlaari® (givosiran)
| 8/20/2025 |
| 10/1/2025 |
Givlaari® (givosiran)
| 8/20/2025 |
| 1/1/2020 |
Gleostine (lomustine)
| 12/10/2025 |
| 1/1/2019 |
GLP-1 Analogs
| 3/20/2024 |
| 1/1/2025 |
Glucagon Products
| 2/19/2025 |
| 1/1/2026 |
Glucagon Products
| 6/18/2025 |
| 8/19/2020 |
GnRH Receptor Antagonists (Myfembree®, Oriahnn®)
| 5/21/2025 |
| 1/1/2026 |
GnRH Receptor Antagonists (Myfembree®, Oriahnn®)
| 5/21/2025 |
| 1/1/2022 |
Gocovri® (amantadine extended release)
| 11/19/2025 |
| 5/28/2025 |
Gomekli (mirdametinib)
| 1/21/2026 |
| 1/1/2020 |
Gralise® (gabapentin)
| 10/15/2025 |
| 1/1/2026 |
Granix® (tbo-filgrastim)
| 1/21/2026 |
| 1/1/2026 |
Granix® (tbo-filgrastim)
| 1/21/2026 |
| 1/1/2021 |
Growth Hormone
| 8/20/2025 |
| 1/1/2022 |
Growth Hormone
| 8/21/2024 |
| 1/1/2025 |
Haegarda (C1 esterase inhibitor, human)
| 1/15/2026 |
| 10/1/2025 |
Haegarda (C1 esterase inhibitor, human)
| 8/20/2025 |
| 9/24/2025 |
Harliku™ (nitisinone)
| 9/17/2025 |
| 1/1/2025 |
Harvoni (Ledipasvir/sofosbuvir)
| 5/21/2025 |
| 1/1/2026 |
Harvoni (ledipasvir/sofosbuvir)
| 7/16/2025 |
| 1/1/2025 |
Helicobacter Pylori Agents
| 5/21/2025 |
| 12/9/2020 |
Hemady (dexamethasone tablet)
| 9/17/2025 |
| 6/1/2023 |
Hemgenix (etranacogene dezaparvovec-drlb)
| 4/16/2025 |
| 1/1/2020 |
Hemlibra® (emicizumab-kxwh)
| 2/18/2026 |
| 3/1/2026 |
Herceptin Hylecta (trastuzumab and hyaluronidase- oysk)
| 1/21/2026 |
| 3/1/2026 |
Herceptin Hylecta (trastuzumab and hyaluronidase- oysk)
| 1/21/2026 |
| 3/1/2026 |
Herceptin Hylecta (trastuzumab and hyaluronidase- oysk)
| 1/21/2026 |
| 1/1/2023 |
Herceptin Hylecta (trastuzumab and hyaluronidase-oysk)
| 1/21/2026 |
| 10/22/2025 |
Hernexeos (zongertinib)
| 9/18/2025 |
| 1/1/2025 |
Hetlioz and Hetlioz LQ (tasimelteon)
| 4/16/2025 |
| 1/1/2018 |
Horizant® (gabapentin enacarbil)
| 1/21/2026 |
| 9/28/2022 |
Hyftor™ (sirolimus topical gel)
| 9/17/2025 |
| 2/26/2025 |
Hympavzi Pen subcutaneous pen injector
| 2/18/2026 |
| 1/1/2023 |
Hypomethylating agents (azacitidine, decitabine)
| 6/18/2025 |
| 2/25/2026 |
Hyrnuo (sevabertinib)
| 2/18/2026 |
| 9/26/2006 |
Ibandronate Sodium Injections
| 6/19/2024 |
| 1/1/2025 |
Ibrance (palbociclib)
| 1/21/2026 |
| 1/1/2024 |
Ibsrela® (tenapanor)
| 7/16/2025 |
| 8/27/2025 |
Ibtrozi (taletrectinib)
| 8/20/2025 |
| 1/1/2022 |
Iclusig® (ponatinib)
| 4/16/2025 |
| 1/1/2023 |
Icosapent Ethyl (generic Vascepa)
| 6/19/2024 |
| 1/1/2020 |
Idhifa® (enasidenib)
| 10/15/2025 |
| 2/28/2024 |
iDose® TR (travoprost) intracameral implant
| 11/19/2025 |
| 1/1/2026 |
iDose® TR (travoprost) intracameral implant
| 11/19/2025 |
| 1/1/2026 |
iDose® TR (travoprost) intracameral implant
| 11/19/2025 |
| 5/24/2023 |
Igalmi™ (dexmedetomidine)
| 1/21/2026 |
| 8/6/2009 |
Ilaris® (canakinumab)
| 11/19/2025 |
| 11/22/2023 |
Ilumya® (tildrakizumab)
| 9/18/2024 |
| 11/22/2023 |
Ilumya® (tildrakizumab)
| 6/18/2025 |
| 4/2/2015 |
Iluvien® (fluocinolone acetonide) intravitreal implant
| 6/18/2025 |
| 10/22/2025 |
Imaavy intravenous solution (nipocalimab-aahu)
| 10/15/2025 |
| 1/1/2025 |
Imatinib products (Gleevec, Imkeldi)
| 1/21/2026 |
| 1/1/2026 |
Imbruvica® (ibrutinib)
| 5/21/2025 |
| 8/28/2024 |
Imdelltra™ (tarlatamab-dlle)
| 6/18/2025 |
| 1/1/2025 |
Imfinzi (durvalumab)
| 2/18/2026 |
| 1/1/2025 |
Imjudo (tremelimumab-actl)
| 10/15/2025 |
| 12/1/2025 |
Imjudo (tremelimumab-actl)
| 10/15/2025 |
| 12/1/2025 |
Imjudo (tremelimumab-actl)
| 10/15/2025 |
| 12/1/2025 |
Imjudo (tremelimumab-actl)
| 10/15/2025 |
| 1/1/2020 |
Imlygic (talimogene laherparepvec)
| 11/19/2025 |
| 1/1/2026 |
Imlygic (talimogene laherparepvec)
| 11/19/2025 |
| 1/1/2026 |
Imlygic (talimogene laherparepvec)
| 11/19/2025 |
| 1/1/2026 |
Imlygic (talimogene laherparepvec)
| 11/19/2025 |
| 1/1/2022 |
Inbrija® (inhaled levodopa)
| 3/20/2024 |
| 1/1/2022 |
Inbrija® (inhaled levodopa)
| 1/21/2026 |
| 11/23/2005 |
Increlex® (mecasermin injection)
| 1/21/2026 |
| 7/1/2024 |
Indiana Opioid Days' Supply Limitation
| 6/13/2024 |
| 1/1/2022 |
Ingrezza® & Ingrezza Sprinkle (valbenazine)
| 8/20/2025 |
| 1/1/2016 |
Inhaled Anticholinergics
| 3/20/2024 |
| 1/1/2025 |
Inhaled Anticholinergics
| 10/15/2025 |
| 1/1/2024 |
Inhaled Corticosteroid and Long-Acting Beta Agonist (ICS/LABA) Inhalers
| 5/15/2024 |
| 1/1/2024 |
Inhaled Corticosteroid and Long-Acting Beta Agonist (ICS/LABA) Inhalers
| 5/15/2024 |
| 1/1/2025 |
Inhaled Corticosteroid and Long-Acting Beta Agonist (ICS/LABA) Inhalers
| 6/18/2025 |
| 1/1/2025 |
Inhaled Corticosteroid and Long-Acting Beta Agonist (ICS/LABA) Inhalers
| 3/19/2025 |
| 1/1/2026 |
Inhaled Corticosteroid and Long-Acting Beta Agonist (ICS/LABA) Inhalers
| 5/21/2025 |
| 1/1/2024 |
Inhaled Corticosteroids
| 4/17/2024 |
| 12/17/2025 |
Inlexzo (gemcitabine intravesical system)
| 12/10/2025 |
| 2/1/2026 |
Inlexzo (gemcitabine intravesical system)
| 12/10/2025 |
| 2/1/2026 |
Inlexzo (gemcitabine intravesical system)
| 12/10/2025 |
| 2/1/2026 |
Inlexzo (gemcitabine intravesical system)
| 12/10/2025 |
| 11/26/2025 |
Inluriyo (imlunestrant)
| 11/19/2025 |
| 1/1/2026 |
Inlyta (axitinib)
| 5/21/2025 |
| 8/23/2023 |
Inpefa™ (sotagliflozin)
| 5/21/2025 |
| 1/1/2026 |
Inqovi® (decitabine and cedazuridine)
| 5/21/2025 |
| 1/1/2026 |
Inrebic® (fedratinib)
| 5/21/2025 |
| 1/1/2023 |
Intranasal Rhinitis Agents
| 5/21/2025 |
| 1/1/2026 |
Intranasal Rhinitis Agents
| 5/21/2025 |
| 1/1/2022 |
Intravenous Iron Products
| 12/10/2025 |
| 1/1/2024 |
Intravenous Iron Products
| 12/10/2025 |
| 1/1/2026 |
Intravenous Iron Products
| 8/20/2025 |
| 1/1/2026 |
Intravenous Iron Products
| 8/20/2025 |
| 1/1/2019 |
Intravenous tocilizumab products
| 10/15/2025 |
| 1/1/2025 |
Invega (paliperidone extended release)
| 6/18/2025 |
| 9/25/2024 |
Iqirvo® (elafibranor)
| 8/20/2025 |
| 1/1/2024 |
Iressa (gefitinib)
| 1/21/2026 |
| 1/1/2023 |
Istodax (romidepsin)
| 1/21/2026 |
| 3/1/2026 |
Istodax (romidepsin)
| 1/21/2026 |
| 3/1/2026 |
Istodax (romidepsin)
| 1/21/2026 |
| 3/1/2026 |
Istodax (romidepsin)
| 1/21/2026 |
| 9/16/2020 |
Isturisa® (osilodrostat)
| 5/21/2025 |
| 12/18/2024 |
Itovebi (inavolisib)
| 10/15/2025 |
| 1/28/2026 |
Itvisma (onasemnogene abeparvovec-brve)
| 1/21/2026 |
| 3/1/2026 |
Itvisma (onasemnogene Abeparvovec-brve)
| 1/21/2026 |
| 7/1/2024 |
IVIG (immune globulin)
| 10/15/2025 |
| 1/1/2026 |
IVIG (immune globulin)
| 10/15/2025 |
| 1/1/2026 |
IVIG (immune globulin)
| 10/15/2025 |
| 1/1/2026 |
IVIG (immune globulin)
| 12/30/2025 |
| 2/28/2024 |
Iwilfin (eflornithine)
| 1/21/2026 |
| 11/1/2025 |
Ixempra (ixabepilone)
| 9/17/2025 |
| 11/1/2025 |
Ixempra (ixabepilone)
| 9/17/2025 |
| 11/1/2025 |
Ixempra (ixabepilone)
| 9/17/2025 |
| 1/1/2017 |
Ixempra® (ixabepilone)
| 9/17/2025 |
| 9/27/2023 |
Izervay™ (avacincaptad pegol)
| 12/10/2025 |
| 2/1/2026 |
Izervay™ (avacincaptad pegol)
| 12/10/2025 |
| 2/1/2026 |
Izervay™ (avacincaptad pegol)
| 12/10/2025 |
| 1/1/2020 |
Jakafi® (ruxolitinib)
| 9/17/2025 |
| 11/26/2025 |
Jascayd® (nerandomilast)
| 2/18/2026 |
| 4/26/2023 |
Jaypirca (pirtobrutinib)
| 12/10/2025 |
| 7/15/2020 |
Jelmyto (mitomycin)
| 11/19/2025 |
| 1/1/2026 |
Jelmyto (mitomycin)
| 11/19/2025 |
| 1/1/2026 |
Jelmyto (mitomycin)
| 11/19/2025 |
| 1/1/2026 |
Jelmyto (mitomycin)
| 11/19/2025 |
| 8/1/2021 |
Jemperli (dostarlimab-gxly)
| 9/17/2025 |
| 11/1/2025 |
Jemperli (dostarlimab-gxly)
| 9/17/2025 |
| 11/1/2025 |
Jemperli (dostarlimab-gxly)
| 9/17/2025 |
| 11/1/2025 |
Jemperli (dostarlimab-gxly)
| 9/17/2025 |
| 1/1/2020 |
Jevtana® (cabazitaxel)
| 7/16/2025 |
| 9/1/2025 |
Jevtana® (cabazitaxel)
| 7/16/2025 |
| 9/1/2025 |
Jevtana® (cabazitaxel)
| 7/16/2025 |
| 9/1/2025 |
Jevtana® (cabazitaxel)
| 7/16/2025 |
| 9/27/2023 |
Joenja® (leniolisib)
| 8/20/2025 |
| 4/23/2025 |
Journavx® (suzetrigine)
| 2/18/2026 |
| 1/1/2026 |
Juxtapid® (lomitapide)
| 7/16/2025 |
| 6/26/2024 |
Jylamvo® (methotrexate) oral solution
| 12/10/2025 |
| 1/1/2023 |
Jynarque® (tolvaptan)
| 2/18/2026 |
| 1/1/2020 |
Kadcyla (ado-trastuzumab emtansine)
| 11/19/2025 |
| 1/1/2026 |
Kadcyla (ado-trastuzumab emtansine)
| 11/19/2025 |
| 1/1/2026 |
Kadcyla (ado-trastuzumab emtansine)
| 11/19/2025 |
| 1/1/2026 |
Kadcyla (ado-trastuzumab emtansine)
| 11/19/2025 |
| 1/1/2025 |
Kalbitor (ecallantide)
| 8/20/2025 |
| 10/1/2025 |
Kalbitor (ecallantide)
| 8/20/2025 |
| 11/1/2025 |
Kanuma® (sebelipase alfa)
| 9/17/2025 |
| 1/20/2016 |
Kanuma® (sebelipase alfa)
| 9/17/2025 |
| 8/15/2018 |
Kapspargo™ Sprinkle (metoprolol succinate)
| 11/19/2025 |
| 11/17/2021 |
Kerendia® (finerenone)
| 11/19/2025 |
| 11/17/2021 |
Kerendia® (finerenone)
| 9/18/2024 |
| 1/1/2021 |
Ketoconazole tablet
| 10/15/2025 |
| 1/1/2025 |
Kevzara (sarilumab)
| 7/16/2025 |
| 1/1/2026 |
Kevzara (sarilumab)
| 7/16/2025 |
| 1/1/2022 |
Kevzara® (sarilumab)
| 7/17/2024 |
| 10/1/2025 |
Keytruda (pembrolizumab)
| 8/20/2025 |
| 10/1/2025 |
Keytruda (pembrolizumab)
| 8/20/2025 |
| 10/1/2025 |
Keytruda (pembrolizumab)
| 8/20/2025 |
| 3/23/2022 |
Kimmtrak (tebentafusp-tebn)
| 10/15/2025 |
| 10/22/2025 |
Kimmtrak (tebentafusp-tebn)
| 10/15/2025 |
| 12/1/2025 |
Kimmtrak (tebentafusp-tebn)
| 10/15/2025 |
| 12/1/2025 |
Kimmtrak (tebentafusp-tebn)
| 10/15/2025 |
| 1/1/2025 |
Kineret (anakinra)
| 7/16/2025 |
| 1/1/2026 |
Kineret (anakinra)
| 7/16/2025 |
| 1/1/2022 |
Kineret® (anakinra)
| 9/18/2024 |
| 1/1/2022 |
Kineret® (anakinra)
| 9/18/2024 |
| 1/1/2024 |
Kisqali (ribociclib)
| 1/21/2026 |
| 9/25/2024 |
Kisunla™ (donanemab-azbt)
| 10/15/2025 |
| 4/12/2012 |
Korlym® (mifepristone)
| 12/10/2025 |
| 7/27/2022 |
Korsuva™ (difelikefalin)
| 6/18/2025 |
| 1/1/2022 |
Koselugo (selumetinib)
| 4/16/2025 |
| 3/22/2023 |
Krazati (adagrasib)
| 2/18/2026 |
| 1/1/2020 |
Krystexxa® (pegloticase)
| 1/21/2026 |
| 3/1/2026 |
Krystexxa® (pegloticase)
| 1/21/2026 |
| 3/1/2026 |
Krystexxa® (pegloticase)
| 1/21/2026 |
| 1/1/2022 |
Kuvan® (sapropterin)
| 8/20/2025 |
| 10/18/2017 |
Kymriah™ (tisagenlecleucel)
| 2/18/2026 |
| 1/1/2023 |
Kymriah™ (tisagenlecleucel)
| 11/19/2025 |
| 7/1/2024 |
Kymriah™ (tisagenlecleucel)
| 11/19/2025 |
| 4/21/2021 |
Kymriah™ (tisagenlecleucel)
| 11/19/2025 |
| 1/1/2022 |
Kyprolis® (carfilzomib)
| 10/15/2025 |
| 8/23/2023 |
LAMZEDE® (velmanase alfa-tycv)
| 5/21/2025 |
| 7/1/2024 |
LAMZEDE® (velmanase alfa-tycv)
| 5/21/2025 |
| 1/1/2026 |
LAMZEDE® (velmanase alfa-tycv)
| 8/20/2025 |
| 1/1/2025 |
Lanreotide Products
| 2/18/2026 |
| 1/28/2026 |
Lasix® ONYU (furosemide)
| 1/21/2026 |
| 10/23/2024 |
Lazcluze (lazertinib)
| 1/21/2026 |
| 1/1/2021 |
Ledipasvir/sofosbuvir
| 3/20/2024 |
| 1/1/2021 |
Lemtrada® (alemtuzumab)
| 10/15/2025 |
| 1/1/2026 |
Lenvima (lenvatinib)
| 5/21/2025 |
| 8/23/2023 |
Leqembi® (lecanemab-irmb)
| 10/15/2025 |
| 1/1/2026 |
Leqembi-Iqlik (lecanemab-irmb) subcutaneous auto-injector
| 1/21/2026 |
| 1/1/2026 |
Leqvio® (inclisiran)
| 9/17/2025 |
| 1/1/2026 |
Leqvio® (inclisiran)
| 7/16/2025 |
| 1/1/2021 |
Letairis® (ambrisentan)
| 10/15/2025 |
| 1/1/2026 |
Leukine® (sargramostim/GM-CSF)
| 1/21/2026 |
| 1/1/2026 |
Leuprolide Acetate (Lupron, Lutrate) and Generic Depot Products
| 5/21/2025 |
| 1/1/2026 |
Leuprolide Acetate Subcutaneous Products (Eligard and Vabrinty)
| 11/19/2025 |
| 4/17/2019 |
Levoleucovorin products
| 9/17/2025 |
| 1/1/2023 |
Levoleucovorin products
| 9/17/2025 |
| 7/1/2024 |
Levoleucovorin products
| 9/17/2025 |
| 9/24/2025 |
Levoleucovorin products
| 9/17/2025 |
| 1/1/2026 |
Levorphanol tablets
| 6/18/2025 |
| 1/1/2026 |
Levothyroxine Oral Solution
| 6/18/2025 |
| 1/1/2024 |
Levothyroxine Products
| 6/19/2024 |
| 12/12/2018 |
Lexette® (halobetasol) Topical Foam
| 5/21/2025 |
| 1/1/2026 |
L-glutamine (Endari) oral powder packet
| 6/18/2025 |
| 12/12/2018 |
Libtayo® (cemiplimab-rwlc)
| 12/10/2025 |
| 2/1/2026 |
Libtayo® (cemiplimab-rwlc)
| 12/10/2025 |
| 2/1/2026 |
Libtayo® (cemiplimab-rwlc)
| 12/10/2025 |
| 2/1/2026 |
Libtayo® (cemiplimab-rwlc)
| 12/10/2025 |
| 1/1/2020 |
Lidocaine 5% topical ointment
| 5/21/2025 |
| 1/1/2026 |
Lidocaine 5% topical ointment
| 5/21/2025 |
| 1/1/2020 |
Lidocaine 5% topical patch
| 11/19/2025 |
| 1/1/2020 |
Lidocaine Patch 5% (Lidoderm®, DermacinRx Lidocan™, Lidocan™ II-V)
| 5/21/2025 |
| 1/1/2026 |
Lidocaine Patch 5% (Lidoderm®, DermacinRx Lidocan™, Lidocan™ II-V)
| 5/21/2025 |
| 1/1/2022 |
Lifetime Dosing Limits
| 9/17/2025 |
| 1/1/2019 |
Limited Day Supply
| 12/23/2025 |
| 10/1/2025 |
Limited Day Supply
| 8/28/2025 |
| 10/1/2025 |
Limited Day Supply
| 10/9/2025 |
| 1/1/2023 |
Liposomal doxorubicin
| 10/15/2025 |
| 10/22/2025 |
Liposomal doxorubicin
| 10/15/2025 |
| 12/1/2025 |
Liposomal doxorubicin
| 10/15/2025 |
| 12/1/2025 |
Liposomal doxorubicin
| 10/15/2025 |
| 9/27/2023 |
Litfulo™ (ritlecitinib)
| 9/17/2025 |
| 1/1/2022 |
Livalo® (pitavastatin)
| 2/18/2026 |
| 11/27/2024 |
Livdelzi® capsule
| 11/19/2025 |
| 12/15/2021 |
Livmarli® (maralixibat)
| 12/10/2025 |
| 1/19/2022 |
Livtencity (maribavir) tablet
| 11/19/2025 |
| 12/20/2023 |
Lodoco® (colchicine)
| 11/19/2025 |
| 1/1/2026 |
Lofexidine (Lucemyra) tablet
| 6/18/2025 |
| 1/1/2024 |
Long Acting Beta Agonists
| 4/16/2025 |
| 1/1/2024 |
Long Acting Insulins
| 3/19/2025 |
| 1/1/2026 |
Long Acting Insulins
| 5/21/2025 |
| 1/1/2025 |
Long Acting Muscarinic Antagonist / Long Acting Beta Agonist Combo Inhalers
| 6/18/2025 |
| 1/1/2026 |
Long Acting Opioids
| 6/18/2025 |
| 1/1/2020 |
Lonsurf® (trifluridine and tipiracil)
| 12/10/2025 |
| 2/28/2024 |
Loqtorzi™ (toripalimab-tpzi)
| 12/10/2025 |
| 2/1/2026 |
Loqtorzi™ (toripalimab-tpzi)
| 12/10/2025 |
| 2/1/2026 |
Loqtorzi™ (toripalimab-tpzi)
| 12/10/2025 |
| 2/1/2026 |
Loqtorzi™ (toripalimab-tpzi)
| 12/10/2025 |
| 1/1/2024 |
Lorbrena (lorlatinib)
| 5/21/2025 |
| 1/1/2026 |
Lorbrena (lorlatinib)
| 2/18/2026 |
| 9/22/2021 |
Loreev XR® (lorazepam)
| 2/18/2026 |
| 1/1/2025 |
Lotronex (alosetron)
| 5/21/2025 |
| 1/1/2023 |
Lotronex® (alosetron HCl)
| 2/21/2024 |
| 1/1/2024 |
Lucentis® (ranibizumab)
| 1/21/2026 |
| 1/1/2025 |
Lucentis® (ranibizumab)
| 1/21/2026 |
| 10/1/2025 |
Lucentis® (ranibizumab)
| 9/17/2025 |
| 10/1/2025 |
Lucentis® (ranibizumab)
| 1/21/2026 |
| 7/1/2024 |
Lucentis® (ranibizumab)
| 1/21/2026 |
| 1/1/2026 |
Lumakras (sotorasib)
| 2/18/2026 |
| 1/1/2011 |
Lumizyme® (alglucosidase alpha)
| 8/20/2025 |
| 7/26/2023 |
Lumryz (sodium oxybate)
| 7/17/2024 |
| 7/26/2023 |
Lumryz (sodium oxybate)
| 7/17/2024 |
| 1/1/2025 |
Lumryz (sodium oxybate)
| 2/18/2026 |
| 1/1/2026 |
Lunsumio (mosunetuzumab-axgb)
| 8/20/2025 |
| 3/22/2023 |
Lunsumio® & Lunsumio Velo™ (mosunetuzumab-axgb)
| 2/18/2026 |
| 5/19/2021 |
Lupkynis® (voclosporin)
| 2/18/2026 |
| 1/1/2020 |
Lutathera (lutetium Lu 177 dotatate)
| 9/17/2025 |
| 11/1/2025 |
Lutathera (lutetium Lu 177 dotatate)
| 9/17/2025 |
| 1/1/2020 |
Luxturna® (voretigene neparvovec-rzyl)
| 12/10/2025 |
| 1/19/2024 |
Luxturna® (voretigene neparvovec-rzyl)
| 12/10/2025 |
| 2/1/2026 |
Luxturna® (voretigene neparvovec-rzyl)
| 12/10/2025 |
| 1/1/2025 |
Lybalvi (olanzapine and samidorphan)
| 11/20/2024 |
| 1/28/2026 |
Lynkuet® (elinzanetant)
| 1/21/2026 |
| 9/24/2025 |
Lynozyfic (linvoseltamab-gcpt)
| 9/17/2025 |
| 1/1/2026 |
Lynparza (olaparib)
| 5/21/2025 |
| 1/1/2020 |
Lyrica® CR (pregabalin)
| 4/16/2025 |
| 1/1/2026 |
Lyrica® CR (pregabalin)
| 5/21/2025 |
| 2/15/2023 |
Lytgobi (futibatinib)
| 8/20/2025 |
| 11/1/2025 |
Margenza (margetuximab-cmkb)
| 9/17/2025 |
| 11/1/2025 |
Margenza (margetuximab-cmkb)
| 9/17/2025 |
| 11/1/2025 |
Margenza (margetuximab-cmkb)
| 9/17/2025 |
| 5/19/2021 |
Margenza (margetuximab-cmkb)
| 9/17/2025 |
| 1/1/2024 |
Mavenclad® (cladribine)
| 8/21/2024 |
| 1/1/2026 |
Mavenclad® (cladribine)
| 6/18/2025 |
| 1/1/2026 |
Mavyret™ (glecaprevir/pibrentasvir)
| 7/16/2025 |
| 6/19/2019 |
Medical Necessity Determinations
| 10/9/2025 |
| 1/1/2023 |
Medical Necessity Determinations
| 11/20/2025 |
| 12/1/2022 |
Medical Necessity Determinations
| 11/20/2025 |
| 7/1/2024 |
Medical Necessity Determinations
| 7/17/2025 |
| 7/1/2024 |
Medical Necessity Determinations
| 12/4/2025 |
| 12/11/2024 |
Medical Necessity Determinations
| 11/25/2025 |
| 7/1/2025 |
Medical Necessity Determinations
| 5/15/2025 |
| 3/11/2026 |
Medical Necessity Determinations
| 3/5/2026 |
| 3/11/2026 |
Medical Necessity Determinations
| 3/5/2026 |
| 4/1/2024 |
Medical Necessity Determinations
| 5/15/2025 |
| 6/21/2012 |
Medication Waste
| 12/10/2025 |
| 1/1/2016 |
Megace® ES (megestrol acetate)
| 8/21/2024 |
| 1/1/2026 |
Mekinist (trametinib)
| 6/18/2025 |
| 1/1/2026 |
Mektovi (binimetinib)
| 6/18/2025 |
| 9/28/2022 |
Meloxicam oral suspension
| 7/17/2024 |
| 1/1/2019 |
Memantine Products
| 11/19/2025 |
| 10/11/2012 |
Member Cost-Share Waiver: Contraceptives
| 11/21/2023 |
| 12/13/2017 |
Mepsevii™ (vestronidase alfa-vjbk)
| 5/21/2025 |
| 11/23/2022 |
Methocarbamol tablet
| 10/15/2025 |
| 1/1/2023 |
Methotrexate Injection (Otrexup®, Rasuvo®)
| 1/17/2024 |
| 1/1/2023 |
Methotrexate Injection (Otrexup®, Reditrex®)
| 12/10/2025 |
| 1/1/2025 |
Miebo® (perfluorohexyloctane ophthalmic solution)
| 6/18/2025 |
| 3/26/2025 |
Miplyffa® (arimoclomol)
| 2/18/2026 |
| 1/1/2022 |
Mircera® (methoxy polyethylene glycol-epoetin beta)
| 11/19/2025 |
| 1/1/2017 |
Modafinil
| 11/19/2025 |
| 10/22/2025 |
Modeyso (dordaviprone)
| 10/15/2025 |
| 1/1/2024 |
Molindone hydrochloride
| 7/17/2024 |
| 10/14/2020 |
Monjuvi® (tafasitamab-cxix)
| 8/20/2025 |
| 10/1/2025 |
Monjuvi® (tafasitamab-cxix)
| 8/20/2025 |
| 10/1/2025 |
Monjuvi® (tafasitamab-cxix)
| 8/20/2025 |
| 10/1/2025 |
Monjuvi® (tafasitamab-cxix)
| 8/20/2025 |
| 1/1/2024 |
Motegrity® (prucalopride)
| 1/21/2026 |
| 11/22/2023 |
Motpoly XR (lacosamide extended release)
| 8/20/2025 |
| 10/17/2018 |
Mulpleta® (lusutrombopag)
| 4/16/2025 |
| 8/24/2007 |
Multi-Source Brands
| 12/10/2025 |
| 1/1/2020 |
Mupirocin Topical Cream
| 11/19/2025 |
| 1/1/2023 |
Muscle Relaxants
| 5/15/2024 |
| 1/1/2025 |
Muscle Relaxants
| 6/18/2025 |
| 1/1/2017 |
Myalept® (metreleptin)
| 9/17/2025 |
| 10/14/2020 |
Mycapssa® (octreotide) delayed-release capsules
| 11/19/2025 |
| 8/18/2021 |
Myfembree® (relugolix, estradiol, and norethindrone acetate)
| 7/17/2024 |
| 1/1/2020 |
Mylotarg® (gemtuzumab ozogamicin)
| 12/10/2025 |
| 2/1/2026 |
Mylotarg® (gemtuzumab ozogamicin)
| 12/10/2025 |
| 2/1/2026 |
Mylotarg® (gemtuzumab ozogamicin)
| 12/10/2025 |
| 2/1/2026 |
Mylotarg® (gemtuzumab ozogamicin)
| 12/10/2025 |
| 1/1/2024 |
Myobloc® (rimabotulinumtoxinB)
| 8/20/2025 |
| 7/1/2024 |
Myobloc® (rimabotulinumtoxinB)
| 8/20/2025 |
| 1/1/2026 |
Myobloc® (rimabotulinumtoxinB)
| 11/19/2025 |
| 3/25/2026 |
Myqorzo™ (aficamten)
| 2/18/2026 |
| 1/1/2013 |
Naglazyme® (galsulfase)
| 4/16/2025 |
| 1/1/2024 |
Namenda XR® (memantine extended-release)
| 7/17/2024 |
| 1/1/2026 |
Namzaric (memantine-donepezil ER)
| 8/20/2025 |
| 1/1/2019 |
Namzaric® (memantine and donepezil extended release)
| 1/17/2024 |
| 1/1/2021 |
Nascobal® (cyanocobalamin)
| 5/15/2024 |
| 5/7/2015 |
Natpara® (parathyroid hormone)
| 6/18/2025 |
| 11/27/2024 |
Neffy® (epinephrine nasal spray)
| 11/19/2025 |
| 12/18/2024 |
Nemluvio® (nemolizumab-ilto)
| 2/19/2025 |
| 1/1/2026 |
Nemluvio® (nemolizumab-ilto)
| 12/10/2025 |
| 1/1/2021 |
Nerlynx (neratinib)
| 12/11/2025 |
| 5/10/2012 |
Neupro® (rotigotine)
| 1/17/2024 |
| 1/1/2026 |
Nexavar (sorafenib)
| 5/21/2025 |
| 10/26/2022 |
Nexiclon™ XR (clonidine ER) tablet
| 9/17/2025 |
| 10/20/2021 |
Nexviazyme™ (avalglucosidase alfa-ngpt) Injection
| 6/18/2025 |
| 1/1/2020 |
Niacin-containing agents
| 1/17/2024 |
| 5/28/2025 |
Niktimvo™ (axatilimab-csfr)
| 5/21/2025 |
| 1/1/2026 |
Nilotinib products (Tasigna, nilotinib)
| 5/21/2025 |
| 1/1/2022 |
Ninlaro® (ixazomib)
| 12/11/2025 |
| 1/1/2019 |
Nitisinone Products
| 2/21/2024 |
| 1/1/2025 |
Nivolumab products (Opdivo, Opdivo Qvantig)
| 6/18/2025 |
| 10/17/2018 |
Nocdurna® (desmopressin)
| 2/19/2025 |
| 1/1/2020 |
Non-Benzodiazepine Hypnotics
| 6/19/2024 |
| 6/3/2020 |
Non-FDA Approved Medications
| 1/21/2026 |
| 10/1/2025 |
Non-FDA Approved Medications
| 9/18/2025 |
| 10/1/2025 |
Non-FDA Approved Medications
| 1/21/2026 |
| 1/1/2019 |
Non-Formulary Exceptions
| 9/19/2025 |
| 1/1/2025 |
Non-preferred adalimumab products
| 6/18/2025 |
| 1/1/2026 |
Non-preferred adalimumab products
| 7/16/2025 |
| 1/1/2024 |
Non-Preferred Continuous Glucose Monitoring Systems
| 9/17/2025 |
| 7/1/2024 |
Non-Preferred Exceptions
| 7/24/2025 |
| 1/1/2026 |
Non-Preferred Filgrastim Products
| 1/21/2026 |
| 1/1/2026 |
Non-Preferred Filgrastim Products: Neupogen, Nypozi, Releuko
| 1/21/2026 |
| 1/1/2026 |
Non-Preferred GLP-1 Agonists and GLP-1/GIP Agonists
| 7/16/2025 |
| 1/1/2024 |
Non-Preferred Infliximab products - Renflexis (infliximab-abda) and Avsola (infliximab-axxq)
| 6/19/2024 |
| 1/1/2024 |
Non-Preferred Infliximab Products - Renflexis (infliximab-abda), Avsola (infliximab-axxq)
| 6/18/2025 |
| 1/1/2024 |
Non-Preferred Infliximab Products - Renflexis (infliximab-abda), Avsola (infliximab-axxq), Remicade (infliximab), unbranded Infliximab
| 6/18/2025 |
| 7/1/2024 |
Non-Preferred Infliximab Products - Renflexis (infliximab-abda), Avsola (infliximab-axxq), Remicade (infliximab), unbranded Infliximab
| 6/18/2025 |
| 1/1/2026 |
Non-Preferred Multiple Sclerosis Injectable Products
| 6/18/2025 |
| 1/1/2023 |
Non-Preferred Multiple Sclerosis Interferons
| 8/21/2024 |
| 1/1/2024 |
Non-Preferred Multiple Sclerosis Interferons
| 4/16/2025 |
| 1/1/2024 |
Non-Preferred Oral Multiple Sclerosis Products
| 7/17/2024 |
| 1/1/2024 |
Non-Preferred Oral Multiple Sclerosis Products
| 4/16/2025 |
| 1/1/2026 |
Non-Preferred Oral Multiple Sclerosis Products
| 6/18/2025 |
| 1/1/2026 |
Non-Preferred Pegfilgrastim Products
| 2/18/2026 |
| 1/1/2026 |
Non-Preferred Pegfilgrastim Products
| 2/18/2026 |
| 1/1/2026 |
Non-preferred Pegfilgrastim Products: Fylnetra, Nyvepria, Stimufend, Ziextenzo
| 2/18/2026 |
| 1/1/2025 |
Non-Preferred Testosterone Products
| 8/20/2025 |
| 7/1/2025 |
Non-preferred Ustekinumab Products
| 6/18/2025 |
| 1/1/2026 |
Non-preferred Ustekinumab Products
| 7/16/2025 |
| 1/1/2023 |
Non-Sedating Antihistamines
| 1/15/2025 |
| 1/1/2026 |
Nonsteroidal Anti-Inflammatory Drug Products
| 12/10/2025 |
| 1/1/2018 |
Northera® (droxidopa)
| 11/19/2025 |
| 1/1/2022 |
Nourianz™ (istradefylline)
| 11/19/2025 |
| 1/1/2014 |
Novarel®, Pregnyl® (human chorionic gonadotropin)
| 6/18/2025 |
| 1/20/2017 |
NovoSeven® RT (Coagulation Factor VIIa [Recombinant])
| 6/18/2025 |
| 1/1/2025 |
Noxafil® (posaconazole)
| 9/17/2025 |
| 1/1/2021 |
Nplate® (romiplostim)
| 4/16/2025 |
| 1/1/2026 |
Nubeqa (darolutamide)
| 8/20/2025 |
| 1/1/2026 |
Nucynta IR (tapentadol) tablet
| 6/18/2025 |
| 1/1/2022 |
Nuedexta® (dextromethorphan and quinidine)
| 4/16/2025 |
| 6/16/2021 |
Nulibry™ (fosdenopterin)
| 11/19/2025 |
| 1/1/2026 |
Nulibry™ (fosdenopterin)
| 8/20/2025 |
| 1/1/2021 |
Nuplazid® (pimavanserin)
| 2/18/2026 |
| 1/1/2025 |
Nurtec® ODT (rimegepant)
| 5/21/2025 |
| 1/1/2022 |
Nurtec™ ODT (rimegepant)
| 2/21/2024 |
| 1/1/2024 |
Nurtec™ ODT (rimegepant)
| 3/20/2024 |
| 1/1/2018 |
Nuvigil® (armodafinil)
| 11/19/2025 |
| 1/1/2025 |
Obesity Medications
| 3/19/2025 |
| 1/20/2017 |
Obizur [antihemophilic (recombinant), porcine sequence]
| 6/18/2025 |
| 1/1/2024 |
Ocaliva® (obeticholic acid)
| 1/21/2026 |
| 1/1/2024 |
Ocrevus® (ocrelizumab) & Ocrevus Zunovo™ (ocrelizumab and hyaluronidase-ocsq)
| 10/15/2025 |
| 1/1/2026 |
Ocrevus® (ocrelizumab) & Ocrevus Zunovo™ (ocrelizumab and hyaluronidase-ocsq)
| 6/18/2025 |
| 1/1/2024 |
Octreotide Products
| 7/17/2024 |
| 10/29/2015 |
Odomzo® (sonidegib)
| 9/17/2025 |
| 1/1/2021 |
Ofev® (nintedanib)
| 6/18/2025 |
| 2/28/2024 |
Ogsiveo (nirogacestat)
| 1/29/2026 |
| 10/23/2024 |
Ohtuvayre ™(ensifentrine)
| 10/15/2025 |
| 6/26/2024 |
Ojemda (tovorafenib)
| 1/21/2026 |
| 1/1/2026 |
Ojjaara (momelotinib)
| 5/21/2025 |
| 1/1/2023 |
Olinvyk® (olicerdine)
| 3/19/2025 |
| 1/1/2025 |
Olumiant (baricitinib)
| 4/16/2025 |
| 1/1/2026 |
Olumiant (baricitinib)
| 7/16/2025 |
| 7/1/2022 |
Olumiant® (baricitinib)
| 9/18/2024 |
| 7/1/2022 |
Olumiant® (baricitinib)
| 9/18/2024 |
| 1/1/2017 |
Omeprazole/Sodium Bicarbonate Products
| 12/10/2025 |
| 1/1/2025 |
Omvoh (mirikizumab)
| 6/18/2025 |
| 5/28/2025 |
Onapgo® (apomorphine)
| 1/21/2026 |
| 1/1/2018 |
Oncaspar® (pegaspargase)
| 12/10/2025 |
| 2/1/2026 |
Oncaspar® (pegaspargase)
| 12/10/2025 |
| 2/1/2026 |
Oncaspar® (pegaspargase)
| 12/10/2025 |
| 2/1/2026 |
Oncaspar® (pegaspargase)
| 12/10/2025 |
| 1/1/2024 |
Onfi® (clobazam)
| 4/17/2024 |
| 1/1/2025 |
Onfi® (clobazam)
| 5/21/2025 |
| 1/1/2026 |
Onfi® (clobazam)
| 5/21/2025 |
| 12/9/2020 |
Ongentys® (opicapone)
| 8/20/2025 |
| 1/20/2016 |
Onivyde (liposomal irinotecan)
| 7/16/2025 |
| 9/1/2025 |
Onivyde (liposomal irinotecan)
| 7/16/2025 |
| 9/1/2025 |
Onivyde (liposomal irinotecan)
| 7/16/2025 |
| 9/1/2025 |
Onivyde (liposomal irinotecan)
| 7/16/2025 |
| 1/1/2023 |
Onpattro® (patisiran)
| 4/16/2025 |
| 1/1/2026 |
Onureg™ (azacitidine)
| 5/21/2025 |
| 4/13/2022 |
Opdualag (nivolumab and relatlimab-rmbw)
| 3/19/2025 |
| 1/1/2023 |
Opdualag (nivolumab and relatlimab-rmbw)
| 3/19/2025 |
| 3/27/2024 |
Opfolda® (miglustat)
| 12/10/2025 |
| 1/1/2020 |
Ophthalmic Antibiotics
| 5/21/2025 |
| 1/1/2026 |
Ophthalmic Antibiotics
| 5/21/2025 |
| 1/1/2025 |
Ophthalmic Beta Blockers
| 6/18/2025 |
| 1/1/2025 |
Ophthalmic Cyclosporine (Cequa®, Restasis®, Restasis MultiDose®, Vevye®)
| 6/18/2025 |
| 1/1/2020 |
Ophthalmic Non-Steroidal Anti-Inflammatory Drugs
| 8/20/2025 |
| 1/1/2024 |
Ophthalmic Prostaglandins
| 9/17/2025 |
| 1/1/2024 |
Ophthalmic Steroids
| 2/18/2026 |
| 10/1/2025 |
Opioid Days Supply
| 11/13/2025 |
| 1/1/2019 |
Opioid Days' Supply Limitation
| 10/24/2024 |
| 4/1/2024 |
Opioid Days' Supply Limitation
| 11/21/2024 |
| 7/1/2024 |
Opioid Days' Supply Limitation
| 6/13/2024 |
| 1/1/2025 |
Opioid Overdose Reversal Medications (Zimhi™)
| 3/19/2025 |
| 1/1/2026 |
Opioid Use Disorder (Suboxone Film)
| 6/18/2025 |
| 2/1/2021 |
Opioid Utilization Program - Concurrent Use of Opioids and Benzodiazepines (COB) edits
| 11/21/2024 |
| 7/1/2024 |
Opioid Utilization Program - Concurrent Use of Opioids and Benzodiazepines (COB) edits
| 6/17/2025 |
| 10/1/2025 |
Opioid Utilization Program - Concurrent Use of Opioids/Benzodiazepines and Buprenorphine
| 5/15/2025 |
| 10/1/2025 |
Opioid Utilization Program - Morphine Milligram Equivalent (MME)
| 5/15/2025 |
| 7/1/2025 |
Opioid Utilization Program - Morphine Milligram Equivalent (MME)
| 5/29/2025 |
| 1/1/2021 |
Opioid Utilization Program - Morphine Milligram Equivalent (MME) edits
| 11/21/2024 |
| 1/1/2021 |
Opioid Utilization Program - Morphine Milligram Equivalents (MME) edits
| 11/21/2024 |
| 7/1/2021 |
Opioid Utilization Program - Morphine Milligram Equivalents (MME) edits
| 12/11/2025 |
| 3/12/2026 |
Opioid Utilization Program - Morphine Milligram Equivalents (MME) edits
| 3/12/2026 |
| 4/1/2024 |
Opioid Utilization Program - Morphine Milligram Equivalent (MME) edits
| 11/13/2025 |
| 1/22/2025 |
Opipza™ oral film
| 1/15/2025 |
| 1/1/2026 |
Opipza™ oral film
| 10/15/2025 |
| 2/2/2022 |
Opsumit® (macitentan)/Opsynvi® (macitentan and tadalfil)
| 4/16/2025 |
| 1/1/2026 |
Opsumit® (macitentan)/Opsynvi® (macitentan and tadalfil)
| 8/20/2025 |
| 1/1/2026 |
Opsumit® (macitentan)/Opsynvi® (macitentan and tadalfil)
| 11/19/2025 |
| 1/1/2026 |
Opzelura™ (ruxolitinib)
| 5/21/2025 |
| 1/1/2020 |
Oral Acne Antibiotics
| 7/16/2025 |
| 1/1/2022 |
Oral Acne Antibiotics
| 4/17/2024 |
| 1/1/2021 |
Oral Isotretinoin Products
| 2/18/2026 |
| 1/1/2021 |
Oral Penicillamine Products
| 11/19/2025 |
| 1/1/2026 |
Orencia (abatacept) Intravenous
| 7/16/2025 |
| 1/1/2026 |
Orencia (abatacept) Subcutaneous
| 7/16/2025 |
| 1/1/2025 |
Orenitram® (treprostinil)
| 3/19/2025 |
| 1/1/2026 |
Orenitram® (treprostinil)
| 8/20/2025 |
| 1/1/2026 |
Orgovyx (relugolix)
| 5/21/2025 |
| 10/17/2018 |
Orilissa® (elagolix)
| 6/18/2025 |
| 1/1/2025 |
Orladeyo (berotralstat)
| 8/20/2025 |
| 6/19/2019 |
Orphenadrine Products
| 5/21/2025 |
| 1/1/2026 |
Orphenadrine Products
| 5/21/2025 |
| 4/19/2023 |
Orserdu (elacestrant)
| 10/15/2025 |
| 10/14/2020 |
Ortikos™ (budesonide extended-release)
| 12/10/2025 |
| 6/20/2018 |
Osmolex ER™ (amantadine extended release)
| 11/19/2025 |
| 1/1/2020 |
Osphena® (ospemifene)
| 2/19/2025 |
| 1/1/2026 |
Osphena® (ospemifene)
| 5/21/2025 |
| 1/1/2026 |
Otezla (apremilast)
| 9/17/2025 |
| 1/1/2023 |
Otezla® (apremilast)
| 6/19/2024 |
| 1/1/2022 |
Otic Antibiotics
| 2/21/2024 |
| 1/1/2025 |
Overactive Bladder Agents
| 5/21/2025 |
| 5/8/2020 |
Oxbryta™ (voxelotor)
| 6/18/2025 |
| 1/16/2019 |
Oxervate® (cenegermin) ophthalmic solution
| 2/19/2025 |
| 1/1/2026 |
Oxervate® (cenegermin) ophthalmic solution
| 5/21/2025 |
| 1/1/2026 |
Oxervate® (cenegermin) ophthalmic solution
| 2/18/2026 |
| 4/21/2021 |
Oxlumo® (lumasiran)
| 9/17/2025 |
| 1/1/2020 |
Oxtellar XR® (oxcarbazepine extended release)
| 10/15/2025 |
| 1/1/2026 |
Oxycodone-Acetaminophen Products
| 6/18/2025 |
| 10/14/2009 |
Ozurdex® (dexamethasone intravitreal implant)
| 11/19/2025 |
| 1/1/2026 |
Ozurdex® (dexamethasone intravitreal implant)
| 11/19/2025 |
| 1/1/2026 |
Ozurdex® (dexamethasone intravitreal implant)
| 11/19/2025 |
| 3/18/2020 |
Padcev (enfortumab vedotin-ejfv)
| 12/10/2025 |
| 2/1/2026 |
Padcev (enfortumab vedotin-ejfv)
| 12/10/2025 |
| 2/1/2026 |
Padcev (enfortumab vedotin-ejfv)
| 12/10/2025 |
| 2/1/2026 |
Padcev (enfortumab vedotin-ejfv)
| 12/10/2025 |
| 4/15/2020 |
Palforzia® (peanut allergen powder)
| 6/18/2025 |
| 1/1/2026 |
Palonosetron IV (Aloxi generics)
| 11/19/2025 |
| 11/26/2025 |
Palonosetron IV (Aloxi generics)
| 2/18/2026 |
| 1/1/2026 |
Palonosetron IV (Aloxi generics)
| 11/19/2025 |
| 1/28/2026 |
Palsonify™ (paltusotine)
| 1/21/2026 |
| 8/15/2018 |
Palynziq™ (pegvaliase-pqpz) Injection
| 1/21/2026 |
| 1/1/2016 |
Pancreatic Enzymes
| 8/20/2025 |
| 1/1/2025 |
Panhematin® (heme for injection) intravenous solution
| 8/20/2025 |
| 8/27/2025 |
Panhematin® (heme for injection) intravenous solution
| 8/20/2025 |
| 1/1/2022 |
Panretin® (alitretinoin)
| 12/10/2025 |
| 10/22/2025 |
Papzimeos™ (zopapogene imadenovec-drba)
| 10/15/2025 |
| 10/22/2025 |
Papzimeos™ (zopapogene imadenovec-drba)
| 10/15/2025 |
| 1/1/2019 |
Parsabiv® (etelcalcetide) intravenous solution
| 2/19/2025 |
| 7/1/2024 |
Parsabiv® (etelcalcetide) intravenous solution
| 2/19/2025 |
| 7/1/2025 |
Parsabiv® (etelcalcetide) intravenous solution
| 1/21/2026 |
| 3/1/2026 |
Parsabiv® (etelcalcetide) intravenous solution
| 1/21/2026 |
| 1/1/2019 |
Pediatric Antipsychotic Utilization Program
| 4/24/2025 |
| 10/1/2025 |
Pediatric Antipsychotic Utilization Program
| 8/28/2025 |
| 12/9/2020 |
Pediatric Adrenocortical Insufficiency Products
| 9/17/2025 |
| 11/30/2022 |
Pedmark® (sodium thiosulfate injection)
| 8/20/2025 |
| 8/27/2025 |
Pedmark® (sodium thiosulfate injection)
| 8/20/2025 |
| 1/1/2026 |
Pedmark® (sodium thiosulfate injection)
| 8/20/2025 |
| 1/1/2025 |
Pegasys (peginterferon alfa2-a)
| 5/21/2025 |
| 1/1/2026 |
Pegasys (peginterferon alfa2-a)
| 7/16/2025 |
| 6/3/2020 |
Pemazyre (pemigatinib)
| 6/18/2025 |
| 1/1/2025 |
Pembrolizumab products (Keytruda, Keytruda Qlex)
| 12/10/2025 |
| 2/1/2026 |
Pembrolizumab products (Keytruda, Keytruda Qlex)
| 12/17/2025 |
| 2/1/2026 |
Pembrolizumab products (Keytruda, Keytruda Qlex)
| 12/17/2025 |
| 2/1/2026 |
Pembrolizumab products (Keytruda, Keytruda Qlex)
| 12/17/2025 |
| 4/27/2022 |
Pemetrexed Products
| 9/17/2025 |
| 11/1/2025 |
Pemetrexed Products
| 9/17/2025 |
| 11/1/2025 |
Pemetrexed Products
| 9/17/2025 |
| 11/1/2025 |
Pemetrexed Products
| 9/17/2025 |
| 1/1/2025 |
Pennsaid (diclofenac topical solution)
| 5/21/2025 |
| 1/1/2026 |
Pennsaid (diclofenac topical solution)
| 10/15/2025 |
| 1/1/2020 |
Perjeta (pertuzumab)
| 1/21/2026 |
| 3/1/2026 |
Perjeta (pertuzumab)
| 1/21/2026 |
| 3/1/2026 |
Perjeta (pertuzumab)
| 1/21/2026 |
| 3/1/2026 |
Perjeta (pertuzumab)
| 1/21/2026 |
| 12/28/2022 |
Pheburane® and Olpruva™ (sodium phenylbutyrate)
| 2/18/2026 |
| 9/16/2020 |
Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
| 12/10/2025 |
| 2/1/2026 |
Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
| 12/10/2025 |
| 2/1/2026 |
Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
| 12/10/2025 |
| 2/1/2026 |
Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
| 12/10/2025 |
| 1/1/2025 |
PiaSky® (crovalimab-akkz) injection solution
| 7/16/2025 |
| 1/1/2025 |
Piqray (alpelisib)
| 9/17/2025 |
| 8/1/2025 |
Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
| 6/18/2025 |
| 6/22/2022 |
Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
| 6/18/2025 |
| 1/1/2026 |
Polivy™ (polatuzumab vedotin-piiq)
| 5/21/2025 |
| 1/1/2022 |
Pomalyst® (pomalidomide)
| 2/18/2026 |
| 3/27/2024 |
Pombiliti® (cipaglucosidase alfa-atga)
| 12/10/2025 |
| 2/1/2026 |
Pombiliti® (cipaglucosidase alfa-atga)
| 12/10/2025 |
| 1/1/2020 |
Portrazza (necitumumab)
| 11/19/2025 |
| 10/17/2018 |
Poteligeo® (mogamulizumab-kpkc)
| 1/21/2026 |
| 3/1/2026 |
Poteligeo® (mogamulizumab-kpkc)
| 1/21/2026 |
| 3/1/2026 |
Poteligeo® (mogamulizumab-kpkc)
| 1/21/2026 |
| 3/1/2026 |
Poteligeo® (mogamulizumab-kpkc)
| 1/21/2026 |
| 4/26/2023 |
Pradaxa® (dabigatran etexilate) oral pellet
| 10/15/2025 |
| 1/1/2026 |
Praluent® (alirocumab)
| 1/21/2026 |
| 1/1/2025 |
Prandial and Intermediate Acting Insulins
| 3/19/2025 |
| 1/1/2026 |
Prandial and Intermediate Acting Insulins
| 7/16/2025 |
| 1/1/2026 |
Preferred Adalimumab Products
| 7/16/2025 |
| 1/1/2024 |
Preferred Continuous Glucose Monitoring Systems
| 9/17/2025 |
| 1/1/2026 |
Preferred Filgrastim Products
| 1/21/2026 |
| 1/1/2025 |
Preferred Filgrastim Products - Nivestym (filgrastim-aafi) and Zarxio (filgrastim-sndz)
| 2/19/2025 |
| 1/1/2026 |
Preferred Filgrastim Products (MA/MAPD): Zarxio, Nivestym
| 1/21/2026 |
| 1/1/2026 |
Preferred Filgrastim Products (PDP): Nivestym
| 1/21/2026 |
| 1/1/2025 |
Preferred GLP-1 Agonists and GLP-1/GIP Agonists
| 7/16/2025 |
| 1/1/2024 |
Preferred Infliximab Products - Inflectra (infliximab-dyyb)
| 6/18/2025 |
| 7/1/2024 |
Preferred Infliximab Products - Inflectra (infliximab-dyyb)
| 6/18/2025 |
| 1/1/2024 |
Preferred Infliximab Products - Remicade (infliximab), Inflectra (infliximab-dyyb), and infliximab
| 6/18/2025 |
| 1/1/2024 |
Preferred Multiple Sclerosis Products
| 4/16/2025 |
| 1/1/2026 |
Preferred Multiple Sclerosis Products
| 6/18/2025 |
| 1/1/2026 |
Preferred Pegfilgrastim Products: Neulasta/Neulasta Onpro
| 2/18/2026 |
| 1/1/2026 |
Preferred Pegfilgrastim Products: Neulasta/Neulasta Onpro, Fulphila
| 2/18/2026 |
| 1/1/2026 |
Preferred Pegfilgrastim Products: Neulasta/Neulasta Onpro, Udenyca/Udenyca Onbody, Fulphila
| 2/18/2026 |
| 1/1/2025 |
Preferred Testosterone Products
| 8/20/2025 |
| 7/1/2025 |
Preferred Ustekinumab Products
| 6/18/2025 |
| 6/17/2020 |
Pretomanid
| 3/19/2025 |
| 1/1/2020 |
Previous Treatment/Prior Therapy/Trial
| 10/15/2025 |
| 2/21/2018 |
Prevymis™ (letermovir)
| 10/15/2025 |
| 1/1/2026 |
Prevymis™ (letermovir)
| 8/20/2025 |
| 1/1/2026 |
Prevymis™ (letermovir)
| 8/20/2025 |
| 1/1/2024 |
Prialt® (ziconotide intrathecal infusion)
| 11/19/2025 |
| 6/6/2013 |
Procysbi® (cysteamine)
| 4/16/2025 |
| 1/1/2020 |
Prolia® (denosumab) and biosimilars
| 2/18/2026 |
| 1/1/2021 |
Promacta® (eltrombopag)
| 4/16/2025 |
| 1/1/2026 |
Promacta® (eltrombopag)
| 12/11/2025 |
| 5/13/2010 |
Provenge® (sipuleucel-T)
| 12/10/2025 |
| 2/1/2026 |
Provenge® (sipuleucel-T)
| 12/10/2025 |
| 2/1/2026 |
Provenge® (sipuleucel-T)
| 12/10/2025 |
| 2/1/2026 |
Provenge® (sipuleucel-T)
| 12/10/2025 |
| 1/1/2017 |
Provigil® (modafinil)
| 11/19/2025 |
| 1/1/2023 |
Pyrukynd® (mitapivat)
| 8/20/2025 |
| 6/28/2023 |
Qalsody™ (tofersen)
| 3/19/2025 |
| 1/1/2026 |
Qalsody™ (tofersen)
| 8/20/2025 |
| 7/23/2025 |
Qbrexza® (glycopyrronium) Cloth
| 7/16/2025 |
| 1/1/2026 |
Qelbree® (viloxazine)
| 5/21/2025 |
| 6/25/2025 |
Qfitlia™ (fitusiran) subcutaneous injection
| 2/18/2026 |
| 1/1/2026 |
Qinlock (ripretinib)
| 5/21/2025 |
| 1/1/2025 |
Qualaquin® (quinine sulfate)
| 9/17/2025 |
| 1/1/2017 |
Quantity Limitation
| 11/19/2025 |
| 1/1/2026 |
Qudexy XR®, Trokendi XR® (topiramate)
| 5/21/2025 |
| 1/1/2025 |
Qulipta (atogepant)
| 12/10/2025 |
| 1/1/2026 |
Qutenza® (capsaicin) 8% patch
| 5/21/2025 |
| 1/1/2024 |
Quviviq (daridorexant)
| 12/10/2025 |
| 1/1/2025 |
Radicava® and Radicava ORS® (edaravone)
| 11/19/2025 |
| 1/1/2023 |
Rasuvo® (methotrexate injection)
| 12/10/2025 |
| 3/7/2013 |
Ravicti® (glycerol phenylbutyrate)
| 11/19/2025 |
| 1/1/2022 |
Rayos® (prednisone delayed-release)
| 2/18/2026 |
| 1/1/2025 |
Reblozyl® (luspatercept-aamt)
| 6/18/2025 |
| 1/25/2023 |
Rebyota™ (fecal microbiota, live-jslm)
| 11/19/2025 |
| 1/1/2025 |
Reclast® (zoledronic acid)
| 5/21/2025 |
| 1/1/2026 |
Reclast® (zoledronic acid)
| 2/18/2026 |
| 4/27/2022 |
Recorlev® (levoketoconazole) Tablet
| 11/19/2025 |
| 2/25/2026 |
Redemplo® (plozasiran)
| 2/18/2026 |
| 1/1/2021 |
Regranex® (becaplermin)
| 7/16/2025 |
| 1/1/2024 |
Relistor® (methylnaltrexone)
| 1/21/2026 |
| 3/17/2021 |
Reltone™ (ursodiol capsule)
| 4/16/2025 |
| 1/1/2024 |
Remodulin® (treprostinil)
| 3/19/2025 |
| 1/1/2026 |
Remodulin® (treprostinil)
| 5/21/2025 |
| 1/1/2026 |
Repatha® (evolocumab)
| 12/10/2025 |
| 7/8/2020 |
Retevmo (selpercatinib)
| 1/29/2026 |
| 1/1/2021 |
Revatio® (sildenafil) oral tab
| 12/10/2025 |
| 1/1/2021 |
Revatio® (sildenafil) suspension
| 12/10/2025 |
| 1/1/2026 |
Revcovi (elapegademase-lvlr)
| 8/20/2025 |
| 1/1/2026 |
Revlimid (lenalidomide)
| 2/18/2026 |
| 2/26/2025 |
Revuforj® (revumenib)
| 1/21/2026 |
| 1/1/2025 |
Rexulti® (brexpiprazole)
| 9/17/2025 |
| 9/1/2022 |
Reyvow™ (lasmiditan)
| 3/20/2024 |
| 1/1/2024 |
Reyvow™ (lasmiditan)
| 1/21/2026 |
| 1/1/2026 |
Rezdiffra™ (resmetirom)
| 12/11/2025 |
| 2/22/2023 |
Rezlidhia (olutasidenib)
| 11/19/2025 |
| 10/8/2021 |
Rezurock (belumosudil)
| 9/17/2025 |
| 8/23/2023 |
Rezzayo Intravenous Solution
| 7/16/2025 |
| 2/25/2026 |
Rhapsido® (remibrutinib)
| 2/18/2026 |
| 10/14/2020 |
Rhopressa® (netarsudil), Rocklatan® (netarsudil and latanoprost)
| 9/17/2025 |
| 1/1/2022 |
Ridaura® (auranofin)
| 1/21/2026 |
| 1/1/2026 |
Rinvoq (upadacitinib) Extended Release Tablet
| 11/19/2025 |
| 1/1/2026 |
Rinvoq (upadacitinib) LQ Oral Solution
| 7/16/2025 |
| 1/1/2023 |
Risperidone Orally Disintegrating Tablets
| 2/18/2026 |
| 1/1/2021 |
Rituxan Hycela™ (rituximab/hyaluronidase)
| 4/16/2025 |
| 7/1/2024 |
Rituxan Hycela™ (rituximab/hyaluronidase)
| 4/16/2025 |
| 1/1/2023 |
Rituxan Hycela™ (rituximab/hyaluronidase)
| 4/16/2025 |
| 1/1/2023 |
Rituximab Products
| 8/20/2025 |
| 1/1/2026 |
Rituximab products
| 8/20/2025 |
| 1/1/2026 |
Rituximab products
| 8/20/2025 |
| 1/1/2026 |
Rituximab products
| 8/20/2025 |
| 1/1/2026 |
Rituximab products
| 8/20/2025 |
| 5/22/2024 |
Rivfloza (nedosiran)
| 4/16/2025 |
| 8/31/2023 |
Roctavian™ (valoctocogene roxaparvovec-rvox)
| 4/16/2025 |
| 1/1/2026 |
Rolvedon (eflapegrastim-xnst)
| 2/18/2026 |
| 1/1/2026 |
Rolvedon (eflapegrastim-xnst)
| 2/18/2026 |
| 1/1/2026 |
Rolvedon (eflapegrastim-xnst)
| 2/18/2026 |
| 5/28/2025 |
Romvimza (vimseltinib)
| 1/21/2026 |
| 1/1/2020 |
Rozerem (ramelteon)
| 5/21/2025 |
| 11/1/2019 |
Rozlytrek™ (entrectinib)
| 8/20/2025 |
| 1/1/2026 |
Rubraca (rucaparib)
| 2/18/2026 |
| 1/1/2025 |
Ruconest (C1 esterase inhibitor, recombinant)
| 8/20/2025 |
| 10/1/2025 |
Ruconest (C1 esterase inhibitor, recombinant)
| 8/20/2025 |
| 1/1/2026 |
Rydapt® (midostaurin)
| 5/21/2025 |
| 9/15/2021 |
Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn)
| 7/16/2025 |
| 4/27/2022 |
Ryplazim (plasminogen, human-tvmh)
| 12/10/2025 |
| 2/1/2026 |
Ryplazim (plasminogen, human-tvmh)
| 12/10/2025 |
| 2/1/2026 |
Ryplazim (plasminogen, human-tvmh)
| 12/10/2025 |
| 2/1/2026 |
Ryplazim (plasminogen, human-tvmh).
| 12/10/2025 |
| 1/1/2025 |
Rystiggo (rozanolixizumab-noli)
| 5/21/2025 |
| 1/1/2026 |
Rystiggo (rozanolixizumab-noli)
| 8/20/2025 |
| 10/23/2024 |
Rytelo (imetelstat)
| 10/15/2025 |
| 12/1/2025 |
Rytelo (imetelstat)
| 10/15/2025 |
| 12/1/2025 |
Rytelo (imetelstat)
| 10/15/2025 |
| 12/1/2025 |
Rytelo (imetelstat)
| 10/15/2025 |
| 6/25/2025 |
Ryzneuta (efbemalenograstim alfa-vuxw)
| 2/18/2026 |
| 1/1/2026 |
Ryzneuta (efbemalenograstim alfa-vuxw)
| 2/18/2026 |
| 1/1/2026 |
Ryzneuta (efbemalenograstim alfa-vuxw)
| 2/18/2026 |
| 1/1/2022 |
Samsca® (tolvaptan)
| 2/18/2026 |
| 1/1/2025 |
Sancuso® (granisetron) transdermal patch
| 7/16/2025 |
| 1/1/2024 |
Sandostatin® S.C., Sandostatin LAR® Depot (octreotide acetate for injection)
| 2/18/2026 |
| 1/1/2025 |
Santyl (collagenase)
| 6/18/2025 |
| 11/1/2025 |
Saphnelo™ (anifrolumab-fnia)
| 9/17/2025 |
| 11/1/2025 |
Saphnelo™ (anifrolumab-fnia)
| 9/17/2025 |
| 12/15/2021 |
Saphnelo™ (anifrolumab-fnia)
| 9/17/2025 |
| 1/1/2025 |
Saphris (asenapine)
| 6/18/2025 |
| 1/1/2022 |
Sarclisa (isatuximab-irfc)
| 10/15/2025 |
| 12/1/2025 |
Sarclisa (isatuximab-irfc)
| 10/15/2025 |
| 12/1/2025 |
Sarclisa (isatuximab-irfc)
| 10/15/2025 |
| 12/1/2025 |
Sarclisa (isatuximab-irfc)
| 10/15/2025 |
| 1/1/2026 |
Savaysa® (edoxaban)
| 5/21/2025 |
| 1/1/2025 |
Savella® (milnacipran)
| 12/10/2025 |
| 12/15/2021 |
Scemblix® (asciminib)
| 12/10/2025 |
| 6/17/2020 |
Scenesse® (afamelanotide)
| 11/19/2025 |
| 1/1/2025 |
Secuado (asenapine) Transdermal System
| 6/18/2025 |
| 1/1/2025 |
Seglentis® (celecoxib-tramadol)
| 6/18/2025 |
| 9/24/2025 |
Sephience™ (sepiapterin)
| 9/17/2025 |
| 1/1/2026 |
Seroquel XR (quetiapine fumarate) extended release tablets
| 5/21/2025 |
| 1/1/2020 |
Serostim® (somatropin)
| 1/21/2026 |
| 1/1/2026 |
SGLT2 Inhibitors
| 7/16/2025 |
| 2/20/2019 |
Short Acting Beta Agonists
| 6/18/2025 |
| 3/21/2013 |
Signifor® (pasireotide)
| 2/18/2026 |
| 1/1/2024 |
Signifor® LAR (pasireotide)
| 2/18/2026 |
| 11/1/2025 |
Signifor® LAR (pasireotide)
| 2/18/2026 |
| 1/1/2026 |
Siklos (hydroxyurea) tablet
| 6/18/2025 |
| 1/1/2026 |
Siliq (brodalumab) injection
| 7/16/2025 |
| 1/1/2026 |
Simponi (golimumab)
| 11/19/2025 |
| 1/1/2019 |
Simponi ARIA (golimumab)
| 8/20/2025 |
| 3/21/2018 |
Sinuva® (mometasone furoate) sinus implant
| 10/15/2025 |
| 5/2/2013 |
Sirturo® (bedaquiline)
| 9/17/2025 |
| 6/28/2023 |
Skyclarys™ (omaveloxolone)
| 4/16/2025 |
| 1/1/2022 |
Skyrizi® (risankizumab-rzaa)
| 6/18/2025 |
| 7/7/2019 |
Smart Maintenance Dose
| 9/17/2025 |
| 4/20/2022 |
Soaanz® (torsemide)
| 1/21/2026 |
| 1/28/2026 |
Sofdra (sofpironium)
| 1/21/2026 |
| 1/24/2024 |
Sohonos® (palovarotene)
| 11/19/2025 |
| 1/1/2024 |
Soliris® (eculizumab)
| 7/17/2024 |
| 1/1/2025 |
Soliris® (eculizumab) and biosimilars
| 5/21/2025 |
| 2/21/2018 |
Solosec® (secnidazole)
| 9/17/2025 |
| 1/1/2026 |
Somavert® (pegvisomant)
| 5/21/2025 |
| 1/1/2026 |
Sotyktu (deucravacitinib)
| 7/16/2025 |
| 1/1/2025 |
Sovaldi® (sofosbuvir)
| 5/21/2025 |
| 1/1/2026 |
Sovaldi® (sofosbuvir)
| 7/16/2025 |
| 7/24/2024 |
Spevigo (spesolimab-sbzo) subcutaneous syringe
| 2/18/2026 |
| 11/23/2022 |
Spevigo® (spesolimab-sbzo) intravenous solution
| 2/18/2026 |
| 1/1/2024 |
Spinraza® (nusinersen)
| 1/21/2026 |
| 3/1/2026 |
Spinraza® (nusinersen)
| 1/21/2026 |
| 7/1/2025 |
Spravato™ (esketamine) Nasal Spray
| 5/21/2025 |
| 1/1/2020 |
Spritam® (levetiracetam)
| 10/15/2025 |
| 1/1/2026 |
Sprix (ketorolac tromethamine) nasal spray
| 5/21/2025 |
| 1/1/2025 |
Sprix® (ketorolac tromethamine) nasal spray
| 5/21/2025 |
| 1/1/2022 |
Statin Products
| 11/19/2025 |
| 1/1/2026 |
Stem cell mobilizing agents (Mozobil, Aphexda, Plerixafor)
| 8/20/2025 |
| 1/1/2026 |
Stem cell mobilizing agents (Mozobil, Aphexda, Plerixafor)
| 8/20/2025 |
| 1/1/2026 |
Stem cell mobilizing agents (Mozobil, Aphexda, Plerixafor)
| 5/21/2025 |
| 1/1/2026 |
Stivarga (regorafenib)
| 5/21/2025 |
| 1/1/2025 |
Strensiq® (asfotase alfa)
| 5/21/2025 |
| 1/1/2026 |
Strensiq® (asfotase alfa)
| 8/20/2025 |
| 1/1/2025 |
Subcutaneous tocilizumab products
| 5/21/2025 |
| 1/1/2025 |
Sublingual Allergen Extract
| 5/21/2025 |
| 1/1/2026 |
Sublingual Allergen Extract
| 5/21/2025 |
| 1/1/2025 |
Sucraid® (sacrosidase)
| 5/21/2025 |
| 3/22/2023 |
Sunlenca (lenacapavir)
| 2/21/2024 |
| 1/1/2025 |
Sunosi (solriamfetol)
| 6/18/2025 |
| 7/23/2025 |
Sustol® granisetron
| 7/16/2025 |
| 1/1/2024 |
Susvimo® (ranibizumab)
| 6/18/2025 |
| 1/1/2025 |
Susvimo® (ranibizumab)
| 9/17/2025 |
| 8/1/2025 |
Susvimo® (ranibizumab)
| 6/18/2025 |
| 11/1/2025 |
Susvimo® (ranibizumab)
| 9/17/2025 |
| 1/1/2026 |
Sutent (sunitinib)
| 10/15/2025 |
| 5/24/2023 |
Syfovre® (pegcetacoplan) intravitreal solution
| 12/10/2025 |
| 2/1/2026 |
Syfovre® (pegcetacoplan) intravitreal solution
| 12/10/2025 |
| 2/1/2026 |
Syfovre® (pegcetacoplan) intravitreal solution
| 12/10/2025 |
| 6/12/2014 |
Sylvant® (siltuximab)
| 11/19/2025 |
| 1/1/2026 |
Sylvant® (siltuximab)
| 11/19/2025 |
| 1/1/2026 |
Sylvant® (siltuximab)
| 11/19/2025 |
| 1/1/2026 |
Sylvant® (siltuximab)
| 11/19/2025 |
| 1/1/2025 |
Sympazan® (clobazam oral film)
| 5/21/2025 |
| 1/1/2024 |
Symproic® (naldemedine)
| 1/21/2026 |
| 1/1/2022 |
Synagis® (palivizumab)
| 2/18/2026 |
| 7/1/2024 |
Synagis® (palivizumab)
| 2/18/2026 |
| 7/15/2020 |
Tabrecta (capmatinib)
| 11/19/2025 |
| 1/1/2021 |
Tadalafil Products - PAH Indication Only
| 6/18/2025 |
| 1/1/2026 |
Tafinlar (dabrafenib)
| 6/18/2025 |
| 1/1/2024 |
Tagrisso (osimertinib)
| 8/20/2025 |
| 1/1/2025 |
Takhzyro (lanadelumab-flyo)
| 8/20/2025 |
| 10/1/2025 |
Takhzyro (lanadelumab-flyo)
| 8/20/2025 |
| 1/1/2025 |
Taltz (ixekizumab)
| 6/18/2025 |
| 1/1/2026 |
Taltz (ixekizumab)
| 7/16/2025 |
| 1/1/2022 |
Taltz® (ixekizumab)
| 9/18/2024 |
| 1/1/2022 |
Taltz® (ixekizumab)
| 9/18/2024 |
| 11/22/2023 |
Talvey (talquetamab)
| 9/17/2025 |
| 11/1/2025 |
Talvey (talquetamab)
| 9/17/2025 |
| 11/1/2025 |
Talvey (talquetamab)
| 9/17/2025 |
| 1/1/2026 |
Talvey (talquetamab)
| 8/20/2025 |
| 1/1/2026 |
Talzenna (talazoparib)
| 5/21/2025 |
| 1/1/2026 |
Tarceva (erlotinib)
| 10/15/2025 |
| 2/23/2022 |
Tarpeyo™ (budesonide) delayed-release capsules
| 4/16/2025 |
| 1/1/2024 |
Tasmar® (tolcapone)
| 4/16/2025 |
| 1/1/2021 |
Tavalisse® (fostamatinib)
| 4/16/2025 |
| 3/16/2022 |
Tavneos™ (avacopan)
| 12/10/2025 |
| 1/1/2021 |
Tazorac® (tazarotene cream and gel)
| 2/18/2026 |
| 1/1/2026 |
Tazverik™ (tazemetostat)
| 10/15/2025 |
| 9/16/2020 |
Tecartus™ (brexucabtagene autoleucel)
| 2/18/2026 |
| 1/1/2023 |
Tecartus™ (brexucabtagene autoleucel)
| 11/19/2025 |
| 7/1/2024 |
Tecartus™ (brexucabtagene autoleucel)
| 11/19/2025 |
| 4/21/2021 |
Tecartus™ (brexucabtagene autoleucel)
| 11/19/2025 |
| 11/1/2025 |
Tecvayli (teclistamab-cqyv)
| 9/17/2025 |
| 11/1/2025 |
Tecvayli (teclistamab-cqyv)
| 9/17/2025 |
| 11/1/2025 |
Tecvayli (teclistamab-cqyv)
| 9/17/2025 |
| 1/1/2023 |
Tecvayli (teclistamab-cqyv)
| 9/17/2025 |
| 1/1/2020 |
Temodar (temozolomide)
| 12/10/2025 |
| 1/1/2022 |
Tepezza® (teprotumumab)
| 2/18/2026 |
| 4/7/2021 |
Tepmetko (tepotinib)
| 11/19/2025 |
| 11/27/2024 |
Tevimbra® (tislelizumab-jsgr)
| 4/16/2025 |
| 5/28/2025 |
Tezruly™ (terazosin)
| 5/21/2025 |
| 6/22/2022 |
Tezspire™ (tezepelumab-ekko)
| 11/19/2025 |
| 7/15/2020 |
Thalomid® (thalidomide)
| 2/18/2026 |
| 1/1/2018 |
Thrombate III® [Antithrombin III (Human)]
| 8/20/2025 |
| 8/27/2025 |
Thrombate III® [Antithrombin III (Human)]
| 8/20/2025 |
| 8/27/2025 |
Thrombate III® [Antithrombin III (Human)]
| 8/20/2025 |
| 1/1/2024 |
Thymoglobulin (antithymocyte globulin [rabbit])
| 6/18/2025 |
| 1/1/2020 |
Tibsovo® (ivosidenib)
| 10/15/2025 |
| 12/12/2018 |
Tiglutik® (riluzole)
| 6/18/2025 |
| 1/1/2026 |
Tirosint SOL (levothyroxine sodium solution)
| 6/18/2025 |
| 12/24/2021 |
Tivdak (tisotumab vedotin-tftv)
| 8/20/2025 |
| 1/1/2024 |
Tivdak (tisotumab vedotin-tftv)
| 8/20/2025 |
| 10/1/2025 |
Tivdak (tisotumab vedotin-tftv)
| 8/20/2025 |
| 10/1/2025 |
Tivdak (tisotumab vedotin-tftv)
| 8/20/2025 |
| 1/1/2024 |
Tobramycin for Inhalation
| 1/21/2026 |
| 1/16/2019 |
Tolsura (itraconazole)
| 10/15/2025 |
| 2/25/2026 |
Tonmya™ (cyclobenzaprine)
| 2/18/2026 |
| 1/1/2020 |
Topical Antifungals
| 7/16/2025 |
| 1/1/2025 |
Topical Antivirals
| 6/18/2025 |
| 1/1/2018 |
Topical Doxepin Products (doxepin, Prudoxin®, Zonalon®)
| 5/21/2025 |
| 1/1/2026 |
Topical Doxepin Products (doxepin, Prudoxin®, Zonalon®)
| 5/21/2025 |
| 1/1/2026 |
Topical Imidazole Antifungals (Econazole, Oxistat®)
| 5/21/2025 |
| 1/1/2021 |
Topical Imidazole Antifungals (Econazole, Oxistat®)
| 5/21/2025 |
| 1/1/2026 |
Topical Nystatin Powder
| 12/10/2025 |
| 1/1/2023 |
Topical Onychomycotic Agents
| 2/18/2026 |
| 1/1/2021 |
Topical Psoriasis Agents
| 10/15/2025 |
| 1/1/2019 |
Topical Rosacea Products
| 2/21/2024 |
| 1/1/2019 |
Topical Rosacea Products
| 12/10/2025 |
| 1/1/2023 |
Topical Tazarotene Products (Arazlo®, Fabior®)
| 2/18/2026 |
| 1/1/2021 |
Topical Tretinoin Containing Products
| 2/18/2026 |
| 1/1/2023 |
Topical Vitamin D Products
| 5/21/2025 |
| 1/1/2026 |
Topical Vitamin D Products
| 5/21/2025 |
| 1/1/2024 |
Torisel (temsirolimus)
| 8/20/2025 |
| 8/28/2024 |
Torpenz (everolimus)
| 6/18/2025 |
| 1/1/2026 |
Tramadol extended-release products
| 1/15/2026 |
| 1/1/2024 |
Trastuzumab Products
| 1/15/2025 |
| 1/1/2026 |
Trastuzumab products
| 8/20/2025 |
| 1/1/2026 |
Trastuzumab products
| 8/20/2025 |
| 1/1/2026 |
Trastuzumab products
| 8/20/2025 |
| 1/1/2026 |
Trastuzumab products
| 8/20/2025 |
| 1/1/2026 |
Trelstar (triptorelin pamoate)
| 5/21/2025 |
| 1/1/2025 |
Tremfya (guselkumab)
| 10/15/2025 |
| 7/20/2017 |
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant])
| 12/10/2025 |
| 2/1/2026 |
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant])
| 12/10/2025 |
| 1/1/2022 |
Trintellix (vortioxetine)
| 6/18/2025 |
| 1/1/2019 |
Triptans
| 4/16/2025 |
| 1/1/2026 |
Triptodur™ (triptorelin)
| 6/18/2025 |
| 1/1/2018 |
Trisenox® (arsenic trioxide)
| 1/21/2026 |
| 3/1/2026 |
Trisenox® (arsenic trioxide)
| 1/21/2026 |
| 6/17/2020 |
Trodelvy (sacituzumab govitecan-hziy)
| 11/19/2025 |
| 1/1/2026 |
Trodelvy (sacituzumab govitecan-hziy)
| 11/19/2025 |
| 1/1/2026 |
Trodelvy (sacituzumab govitecan-hziy)
| 11/19/2025 |
| 1/1/2026 |
Trodelvy (sacituzumab govitecan-hziy)
| 11/19/2025 |
| 1/1/2025 |
Trudhesa (dihydroergotamine mesylate)
| 6/18/2025 |
| 1/1/2024 |
Trulance® (plecanatide)
| 7/16/2025 |
| 1/1/2025 |
Truqap (capivasertib)
| 9/17/2025 |
| 8/18/2021 |
Truseltiq (infigratinib)
| 5/15/2024 |
| 2/26/2025 |
Tryngolza ™ (olezarsen)
| 1/21/2026 |
| 9/24/2025 |
Tryptyr® (acoltremon ophthalmic solution)
| 9/17/2025 |
| 7/24/2024 |
Tryvio™ (aprocitentan)
| 5/21/2025 |
| 6/17/2020 |
Tukysa (tucatinib)
| 10/15/2025 |
| 9/18/2019 |
Turalio® (pexidartinib)
| 12/10/2025 |
| 1/1/2026 |
Tyenne (tocilizumab) subcutaneous
| 8/20/2025 |
| 1/1/2026 |
Tyenne (tocilizumab) subcutaneous
| 8/20/2025 |
| 1/1/2023 |
Tykerb (lapatinib)
| 11/19/2025 |
| 1/1/2026 |
Tymlos® (abaloparatide) subcutaneous injection
| 2/18/2026 |
| 1/1/2025 |
Tyrvaya® (varenicline)
| 6/18/2025 |
| 1/1/2024 |
Tysabri® (natalizumab)
| 10/15/2025 |
| 1/1/2025 |
Tysabri® (natalizumab) and biosimilar
| 6/18/2025 |
| 1/1/2026 |
Tysabri® (natalizumab) and biosimilar
| 6/18/2025 |
| 1/1/2024 |
Tyvaso® (treprostinil)
| 4/16/2025 |
| 1/1/2026 |
Tyvaso® (treprostinil)
| 8/20/2025 |
| 4/26/2023 |
Tzield© (teplizumab) intravenous solution
| 10/15/2025 |
| 1/1/2024 |
Ubrelvy™ (ubrogepant)
| 1/21/2026 |
| 1/1/2022 |
Uceris® Tablet and Rectal Foam (budesonide)
| 12/10/2025 |
| 1/1/2025 |
Ulcerative Colitis Agents
| 11/19/2025 |
| 3/5/2009 |
Uloric® (febuxostat)
| 1/21/2026 |
| 1/1/2025 |
Ultomiris® (ravulizumab-cwvz)
| 5/21/2025 |
| 9/3/2015 |
Unituxin (dinutuximab)
| 11/19/2025 |
| 1/1/2026 |
Unituxin (dinutuximab)
| 8/20/2025 |
| 2/25/2026 |
Unloxcyt™ (cosibelimab-ipdl)
| 2/18/2026 |
| 1/1/2022 |
Uplizna® (inebilizumab-cdon)
| 8/20/2025 |
| 1/1/2025 |
Uptravi® (selexipag)
| 3/19/2025 |
| 1/1/2026 |
Uptravi® (selexipag)
| 6/18/2025 |
| 12/1/2025 |
Vabysmo_(faricimab-svoa)_
| 10/15/2025 |
| 5/25/2022 |
Vabysmo® (faricimab-svoa)
| 10/15/2025 |
| 1/1/2023 |
Vabysmo® (faricimab-svoa)
| 10/15/2025 |
| 10/22/2025 |
Vabysmo® (faricimab-svoa)
| 10/15/2025 |
| 1/1/2025 |
Vaginal Atrophy Agents
| 4/16/2025 |
| 1/1/2026 |
Vaginal Atrophy Agents
| 5/21/2025 |
| 1/1/2020 |
Valchlor® (mechlorethamine)
| 1/21/2026 |
| 1/1/2021 |
Valstar (valrubicin)
| 2/18/2026 |
| 1/1/2022 |
Vancomycin
| 6/19/2024 |
| 1/1/2022 |
Vancomycin capsules
| 6/19/2024 |
| 1/1/2026 |
Vanflyta® (quizartinib)
| 5/21/2025 |
| 6/25/2025 |
Vanrafia (atrasentan) tablets
| 6/18/2025 |
| 1/1/2024 |
Varizig (varicella zoster immune globulin)
| 2/18/2026 |
| 1/1/2024 |
Varubi (rolapitant)
| 6/18/2025 |
| 1/1/2024 |
Vectibix (panitumumab)
| 12/10/2025 |
| 2/1/2026 |
Vectibix (panitumumab)
| 12/10/2025 |
| 2/1/2026 |
Vectibix (panitumumab)
| 12/10/2025 |
| 2/1/2026 |
Vectibix (panitumumab)
| 12/10/2025 |
| 1/1/2025 |
Velsipity (etrasimod)
| 6/18/2025 |
| 1/1/2025 |
Veltassa (patiromer)
| 8/20/2025 |
| 1/1/2021 |
Vemlidy® (tenofovir alafenamide)
| 7/17/2024 |
| 1/1/2026 |
Venclexta™ (venetoclax)
| 5/21/2025 |
| 1/1/2025 |
Ventavis® (iloprost)
| 3/19/2025 |
| 1/1/2026 |
Ventavis® (iloprost)
| 8/20/2025 |
| 1/24/2024 |
Veopoz (pozelimab-bbfg)
| 2/18/2026 |
| 7/1/2024 |
Veopoz (pozelimab-bbfg)
| 2/18/2026 |
| 7/26/2023 |
Veozah® (fezolinetant)
| 6/18/2025 |
| 3/26/2025 |
Verkazia® (cyclosporine)
| 3/19/2025 |
| 1/1/2026 |
Verkazia® (cyclosporine)
| 5/21/2025 |
| 4/21/2021 |
Verquvo® (vericiguat)
| 5/21/2025 |
| 1/1/2024 |
Verzenio (abemaciclib)
| 1/21/2026 |
| 1/1/2025 |
Vesicare and Vesicare LS (solifenacin)
| 2/18/2026 |
| 1/1/2009 |
VFEND® (voriconazole)
| 10/15/2025 |
| 1/1/2025 |
V-GO Insulin Delivery Device
| 4/16/2025 |
| 1/1/2026 |
Viberzi® (eluxadoline)
| 7/16/2025 |
| 1/1/2024 |
Vigabatrin products
| 6/18/2025 |
| 1/1/2024 |
Viibryd (vilazodone)
| 4/16/2025 |
| 7/27/2022 |
Vijoice® (alpelisib)
| 2/18/2026 |
| 1/1/2022 |
Viltepso™ (viltolarsen)
| 12/10/2025 |
| 3/6/2014 |
Vimizim® (elosulfase alfa)
| 1/21/2026 |
| 3/1/2026 |
Vimizim® (elosulfase alfa)
| 1/21/2026 |
| 3/1/2026 |
Vimizim® (elosulfase alfa)
| 1/21/2026 |
| 1/1/2020 |
Vimovo® (naproxen-esomeprazole magnesium)
| 1/21/2026 |
| 7/1/2025 |
Virginia Short Acting Opioid Days Supply
| 6/26/2025 |
| 1/1/2024 |
Viscosupplements
| 1/21/2026 |
| 1/1/2024 |
Viscosupplements
| 1/21/2026 |
| 7/1/2024 |
Viscosupplements
| 1/21/2026 |
| 1/1/2026 |
Viscosupplements
| 1/21/2026 |
| 1/1/2022 |
Viscosupplements - Multi Injection
| 1/21/2026 |
| 1/1/2022 |
Viscosupplements - Single Injection
| 1/21/2026 |
| 1/1/2024 |
Visudyne® (verteporfin)
| 2/18/2026 |
| 1/1/2025 |
Visudyne® (verteporfin)
| 2/18/2026 |
| 2/22/2019 |
Vitrakvi (larotrectinib)
| 8/20/2025 |
| 1/1/2025 |
Vivjoa® (oteseconazole)
| 4/16/2025 |
| 1/1/2024 |
Vizimpro (dacomitinib)
| 1/21/2026 |
| 1/20/2017 |
Von Willebrand Factor (VWF)-Containing Products
| 12/10/2025 |
| 1/1/2026 |
Vonjo (pacritinib)
| 5/21/2025 |
| 1/1/2025 |
Voquezna® (vonoprazan)
| 8/20/2025 |
| 9/25/2024 |
Voranigo (vorasidenib)
| 12/10/2025 |
| 1/1/2025 |
Vosevi® (sofosbuvir, velpatasvir, and voxilaprevir)
| 5/21/2025 |
| 1/1/2026 |
Vosevi® (sofosbuvir, velpatasvir, and voxilaprevir)
| 7/16/2025 |
| 1/1/2026 |
Votrient (pazopanib)
| 5/21/2025 |
| 1/1/2025 |
Vowst (fecal microbiota spores, live-brpk)
| 1/21/2026 |
| 2/23/2022 |
Voxzogo™ (vosoritide)
| 10/15/2025 |
| 9/25/2024 |
Voydeya™ (danicopan) tablet
| 7/16/2025 |
| 1/28/2026 |
Voyxact® (sibeprenlimab-szsi) subcutaneous injection
| 1/21/2026 |
| 1/1/2025 |
VPRIV® (velaglucerase alfa)
| 1/21/2026 |
| 3/1/2026 |
VPRIV® (velaglucerase alfa)
| 1/21/2026 |
| 1/1/2025 |
Vraylar (cariprazine)
| 1/21/2026 |
| 1/1/2026 |
Vtama (tapinarof)
| 5/21/2025 |
| 2/26/2025 |
Vyalev® (foscarbidopa/foslevodopa)
| 1/21/2026 |
| 1/1/2025 |
Vyepti® (eptinezumab)
| 9/17/2025 |
| 9/27/2023 |
Vyjuvek™ (beremagene geperpavec-svdt)
| 9/17/2025 |
| 6/25/2025 |
Vykat XR (diazoxide choline)
| 6/18/2025 |
| 11/27/2024 |
Vyloy (zolbetuximab-clzb)
| 8/20/2025 |
| 10/1/2025 |
Vyloy (zolbetuximab-clzb)
| 8/20/2025 |
| 10/1/2025 |
Vyloy (zolbetuximab-clzb)
| 8/20/2025 |
| 10/1/2025 |
Vyloy (zolbetuximab-clzb)
| 8/20/2025 |
| 1/1/2021 |
Vyndaqel®/Vyndamax™ (tafamidis)
| 12/10/2025 |
| 1/1/2025 |
Vyondys 53 (golodirsen)
| 5/21/2025 |
| 1/1/2021 |
Vyvanse® (lisdexamfetamine dimesylate)
| 1/21/2026 |
| 7/1/2024 |
Vyvgart (efgartigimod alfa-fcab) & Vyvgart® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
| 8/20/2025 |
| 3/23/2022 |
Vyvgart® (efgartigimod alfa-fcab) & Vyvgart® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
| 8/20/2025 |
| 6/1/2025 |
Vyvgart® (efgartigimod alfa-fcab) & Vyvgart® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
| 5/1/2025 |
| 1/1/2026 |
Vyvgart® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc)
| 10/15/2025 |
| 10/4/2017 |
Vyxeos™ (daunorubicin and cytarabine) liposome
| 2/18/2026 |
| 4/24/2024 |
Wainua™ (eplontersen)
| 4/16/2025 |
| 1/1/2025 |
Wakix® (pitolisant)
| 2/18/2026 |
| 11/26/2025 |
Wayrilz™ (rilzabrutinib) tablet
| 11/19/2025 |
| 3/28/2024 |
Wegovy (semaglutide)
| 1/21/2026 |
| 11/1/2021 |
Welireg (belzutifan)
| 7/16/2025 |
| 1/1/2023 |
Winlevi® (clascoterone)
| 2/18/2026 |
| 1/1/2026 |
Winrevair™ (sotatercept-csrk)
| 12/10/2025 |
| 7/19/2017 |
Xadago® (safinamide)
| 10/15/2025 |
| 1/1/2026 |
Xalkori (crizotinib)
| 2/18/2026 |
| 1/1/2026 |
Xarelto® (rivaroxaban) oral suspension
| 10/15/2025 |
| 1/1/2025 |
Xatmep™ (methotrexate) oral solution
| 10/15/2025 |
| 1/1/2025 |
Xcopri® (cenobamate)
| 5/21/2025 |
| 11/22/2023 |
Xdemvy® (lotilaner)
| 5/21/2025 |
| 1/1/2026 |
Xdemvy® (lotilaner)
| 5/21/2025 |
| 1/1/2025 |
Xeljanz and Xeljanz XR (tofacitinib)
| 6/18/2025 |
| 1/1/2026 |
Xeljanz and Xeljanz XR (tofacitinib)
| 12/10/2025 |
| 1/1/2022 |
Xeloda (capecitabine)
| 12/10/2025 |
| 1/1/2022 |
Xenazine® (tetrabenazine)
| 6/18/2025 |
| 11/30/2022 |
Xenpozyme™ (olipudase alfa) intravenous solution
| 6/18/2025 |
| 1/1/2026 |
Xenpozyme™ (olipudase alfa) intravenous solution
| 8/20/2025 |
| 1/1/2024 |
Xeomin® (incobotulinumtoxinA)
| 6/18/2025 |
| 7/1/2024 |
Xeomin® (incobotulinumtoxinA)
| 6/18/2025 |
| 1/1/2026 |
Xeomin® (incobotulinumtoxinA)
| 11/19/2025 |
| 1/1/2020 |
Xepi (ozenoxacin) topical cream
| 12/11/2024 |
| 4/5/2017 |
Xermelo™ (telotristat ethyl)
| 10/15/2025 |
| 1/1/2024 |
Xgeva® (denosumab) and biosimilars
| 10/15/2025 |
| 1/1/2026 |
Xgeva® (denosumab) and biosimiliars
| 2/18/2026 |
| 11/8/2017 |
XHANCE® (fluticasone propionate)
| 4/16/2025 |
| 1/1/2024 |
Xifaxan® (rifaximin)
| 6/18/2025 |
| 1/1/2025 |
Xiidra® (lifitegrast ophthalmic solution)
| 6/18/2025 |
| 2/23/2022 |
Xipere® (triamcinolone acetonide)
| 10/15/2025 |
| 10/22/2025 |
Xipere® (triamcinolone acetonide)
| 10/15/2025 |
| 1/1/2023 |
Xofigo® (radium Ra 223 dichloride)
| 5/21/2025 |
| 1/1/2024 |
Xolair® (omalizumab)
| 4/16/2025 |
| 9/25/2024 |
Xolremdi (mavorixafor)
| 8/20/2025 |
| 1/1/2026 |
Xospata® (gilteritinib)
| 5/21/2025 |
| 1/1/2022 |
Xpovio® (selinexor)
| 1/21/2026 |
| 4/23/2025 |
Xromi oral solution
| 4/16/2025 |
| 1/1/2026 |
Xtandi (enzalutamide)
| 5/21/2025 |
| 1/1/2025 |
Xultophy® (insulin degludec and liraglutide)
| 6/18/2025 |
| 1/1/2025 |
Xyrem (sodium oxybate)
| 5/21/2025 |
| 1/1/2025 |
Xywav (calcium, magnesium, potassium, and sodium oxybates)
| 5/21/2025 |
| 11/22/2023 |
Ycanth™ (cantharidin)
| 10/15/2025 |
| 1/1/2025 |
Yervoy (ipilimumab)
| 6/18/2025 |
| 12/13/2017 |
Yescarta™ (axicabtagene ciloleucel)
| 2/18/2026 |
| 7/1/2024 |
Yescarta™ (axicabtagene ciloleucel)
| 11/19/2025 |
| 4/21/2021 |
Yescarta™ (axicabtagene ciloleucel)
| 11/19/2025 |
| 1/1/2023 |
Yescarta™ (axicabtagene ciloleucel)
| 11/19/2025 |
| 1/20/2016 |
Yondelis® (trabectedin)
| 11/19/2025 |
| 1/1/2026 |
Yondelis® (trabectedin)
| 11/19/2025 |
| 1/1/2026 |
Yondelis® (trabectedin)
| 11/19/2025 |
| 1/1/2026 |
Yondelis® (trabectedin)
| 11/19/2025 |
| 1/1/2026 |
Yonsa (abiraterone acetate)
| 5/21/2025 |
| 12/18/2024 |
Yorvipath® (palopegteriparatide)
| 12/10/2025 |
| 2/20/2019 |
Yutiq® (fluocinolone acetonide intravitreal implant)
| 5/21/2025 |
| 1/1/2026 |
Yutrepia™ (treprostinil)
| 8/20/2025 |
| 1/1/2024 |
Zaltrap (ziv-aflibercept)
| 11/19/2025 |
| 1/1/2026 |
Zaltrap (ziv-aflibercept)
| 11/19/2025 |
| 1/1/2026 |
Zaltrap (ziv-aflibercept)
| 11/19/2025 |
| 1/1/2026 |
Zaltrap (ziv-aflibercept)
| 11/19/2025 |
| 1/1/2025 |
Zavesca® (miglustat)
| 1/21/2026 |
| 1/1/2024 |
Zavzpret™ (zavegepant)
| 4/16/2025 |
| 1/1/2026 |
Zejula (niraparib)
| 2/18/2026 |
| 1/1/2026 |
Zelboraf (vemurafenib)
| 6/18/2025 |
| 8/27/2025 |
Zelsuvmi™ (berdazimer)
| 8/20/2025 |
| 1/1/2024 |
Zemaira® (alpha-1 proteinase inhibitor)
| 3/19/2025 |
| 1/1/2026 |
Zemaira® (alpha-1 proteinase inhibitor)
| 7/16/2025 |
| 1/1/2025 |
Zepatier® (elbasvir/grazoprevir)
| 5/21/2025 |
| 1/1/2026 |
Zepatier® (elbasvir/grazoprevir)
| 7/16/2025 |
| 1/20/2025 |
Zepbound® (tirzepatide)
| 8/20/2025 |
| 1/1/2025 |
Zeposia® (ozanimod)
| 6/18/2025 |
| 1/1/2026 |
Zeposia® (ozanimod)
| 6/18/2025 |
| 8/19/2020 |
Zepzelca (lurbinectedin)
| 12/10/2025 |
| 2/1/2026 |
Zepzelca (lurbinectedin)
| 12/10/2025 |
| 2/1/2026 |
Zepzelca (lurbinectedin)
| 12/10/2025 |
| 2/1/2026 |
Zepzelca (lurbinectedin)
| 12/10/2025 |
| 5/20/2015 |
Zevalin® (ibritumomab tiuxetan)
| 12/10/2025 |
| 2/1/2026 |
Zevalin® (ibritumomab tiuxetan)
| 12/10/2025 |
| 1/22/2025 |
Ziihera (zanidatamab-hrii)
| 9/17/2025 |
| 11/1/2025 |
Ziihera (zanidatamab-hrii)
| 9/17/2025 |
| 11/1/2025 |
Ziihera (zanidatamab-hrii)
| 9/17/2025 |
| 11/1/2025 |
Ziihera (zanidatamab-hrii)
| 9/17/2025 |
| 1/1/2025 |
Zilbrysq (zilucoplan)
| 7/16/2025 |
| 1/1/2024 |
Zilretta® (triamcinolone acetonide extended-release injectable suspension)
| 1/21/2026 |
| 7/1/2024 |
Zilretta® (triamcinolone acetonide extended-release injectable suspension)
| 1/21/2026 |
| 3/1/2026 |
Zilretta® (triamcinolone acetonide extended-release injectable suspension)
| 1/21/2026 |
| 3/1/2026 |
Zilretta® (triamcinolone acetonide extended-release injectable suspension)
| 1/21/2026 |
| 7/23/2025 |
Zilxi® (minocycline) Topical Foam
| 7/16/2025 |
| 2/25/2026 |
Zokinvy ™ (lonafarnib)
| 2/18/2026 |
| 1/1/2017 |
Zoladex (goserelin)
| 8/20/2025 |
| 10/1/2025 |
Zoladex (goserelin)
| 8/20/2025 |
| 10/1/2025 |
Zoladex (goserelin)
| 8/20/2025 |
| 10/1/2025 |
Zoladex (goserelin)
| 8/20/2025 |
| 7/1/2024 |
Zolgensma® (onasemnogene abeparvovec-xioi)
| 1/21/2026 |
| 1/1/2020 |
Zolinza® (vorinostat)
| 1/21/2026 |
| 10/26/2022 |
Zonisade™ (zonisamide)
| 6/18/2025 |
| 1/1/2026 |
Zoryve (roflumilast)
| 11/19/2025 |
| 7/27/2022 |
Ztalmy® (ganaxolone)
| 6/18/2025 |
| 1/1/2020 |
ZTlido® (lidocaine topical system)
| 5/21/2025 |
| 1/1/2026 |
ZTlido® (lidocaine topical system)
| 5/21/2025 |
| 1/1/2021 |
Zulresso® (brexanolone)
| 2/18/2026 |
| 9/24/2025 |
Zunveyl tablet,delayed release (benzgalantamine)
| 9/17/2025 |
| 1/1/2026 |
Zurzuvae® (zuranolone)
| 10/15/2025 |
| 8/27/2025 |
Zusduri (mitomycin)
| 8/20/2025 |
| 10/1/2025 |
Zusduri (mitomycin)
| 8/20/2025 |
| 10/1/2025 |
Zusduri (mitomycin)
| 8/20/2025 |
| 10/1/2025 |
Zusduri (mitomycin)
| 8/20/2025 |
| 1/1/2016 |
Zyclara® (imiquimod)
| 10/15/2025 |
| 2/25/2026 |
Zycubo® (copper histidinate) Powder for Injection
| 2/18/2026 |
| 1/1/2023 |
Zydelig® (idelalisib)
| 6/18/2025 |
| 1/1/2026 |
Zykadia (ceritinib)
| 2/18/2026 |
| 1/1/2025 |
Zymfentra (infliximab-dyyb)
| 6/18/2025 |
| 7/21/2021 |
Zynlonta™ (loncastuximab tesirine-Ipyl)
| 6/18/2025 |
| 5/24/2023 |
Zynyz (retifanlimab-dlwr)
| 8/20/2025 |
| 10/1/2025 |
Zynyz (retifanlimab-dlwr)
| 8/20/2025 |
| 10/1/2025 |
Zynyz (retifanlimab-dlwr)
| 8/20/2025 |
| 1/1/2026 |
Zynyz (retifanlimab-dlwr)
| 8/20/2025 |
| 5/1/2021 |
Zypitamag® (pitavastatin)
| 10/15/2025 |
| 1/1/2026 |
Zytiga (abiraterone acetate) and generic abiraterone acetate
| 5/21/2025 |